<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ABB</journal-id><journal-title-group><journal-title>Advances in Bioscience and Biotechnology</journal-title></journal-title-group><issn pub-type="epub">2156-8456</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/abb.2023.144014</article-id><article-id pub-id-type="publisher-id">ABB-124682</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject></subj-group></article-categories><title-group><article-title>
 
 
  Functional Genes in Relation to Residual Feed Intake in Murrah Buffalo Heifers
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Poonam</surname><given-names>Sikka</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Shyam</surname><given-names>Sunder Paul</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Andonissamy</surname><given-names>Jerome</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Dwijesh</surname><given-names>Mishra</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Krishna</surname><given-names>Kumar Chaturvedi</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Anil</surname><given-names>Rai</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Inderjeet</surname><given-names>Singh</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>ICAR, Indian Agricultural Statistics Research Institute, New Delhi, India</addr-line></aff><aff id="aff2"><addr-line>ICAR Project Directorate on Poultry (PDP), Acharya N.G. Ranga Agricultural University Campus, City, Hyderabad, India</addr-line></aff><aff id="aff1"><addr-line>ICAR, Central Institute for Research on Buffaloes, Hisar, Haryana, India</addr-line></aff><pub-date pub-type="epub"><day>18</day><month>04</month><year>2023</year></pub-date><volume>14</volume><issue>04</issue><fpage>210</fpage><lpage>236</lpage><history><date date-type="received"><day>4,</day>	<month>March</month>	<year>2023</year></date><date date-type="rev-recd"><day>25,</day>	<month>April</month>	<year>2023</year>	</date><date date-type="accepted"><day>28,</day>	<month>April</month>	<year>2023</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  High Feed efficiency (FE) in growing heifers has economic importance in dairy, but remains less understood in buffaloes. Feed conversion efficiency is defined as dry matter intake (DMI) per unit body weight gain and is determined as residual feed intake (RFI), 
  i.e.
  , the 
  difference between actual and predicted feed intake to gain unit body weight during a feed trial run for 78 days under control feeding. A large variation was identified ranging between -0.42 to 0.35 in growing buffalo heifers (n
   
  =
   
  40) 
  of 
  age between 11 to 15 months. An average daily weight gain (ADG) varied between 382.0 and 807.6 g/day wh
  en
   compar
  ed
   with the control-fed heifers at 
  an 
  organized buffalo farm. 
  The whole blood transcriptome data obtained from the selected growing heifers from extremes of estimated high and low RFI efficiency were compared with the reference assembly generated from the transcriptome of multiparous buffaloes (n = 16) of diverse age of maturity, period of regaining post partum cyclicity and level of milk production
  . Differentially expressed genes (DEGs) were identified using 
  the 
  reference genome of Mediterranean water buffalo. GO: terms (Padj
   
  &lt;
   
  0.05, FDR
   
  &lt;
   
  0.05) enriched by annotated DEGs and biological pathways in gene network for RFI efficiency trait were identified. GO:
   
  terms specific to pre-transcriptional regulation of nucleus and Chromatin organization under Nucleoplasm, Energy balancing, Immunity, Cell signaling, ROS optimization, ATP generation through 
  the 
  Electron Transport chain and cell proliferation were determined. 
  The 
  study reveals the indicators targeting the actual metabolic changes and molecular functions underlying the feed utilization capacity of buffaloes. Estimated RFI efficiency revealed a large variation over heifers which may lower the DMI even up
   
  to 13.6% thus, enabling 
  an 
  increase in ADG up
   
  to 16% by involving efficient heifers in breeding plan. 
  The 
  study revealed a scope of high gain by selective breeding for FE in heifers. FE variants catalogued in 
  the 
  study are useful breed
  -
  specific RFI markers for future reference. The study contributes to the understanding of feed efficiency in buffaloes and its association with key interactive traits such as reproduction and growth. This knowledge can be utilized to develop more effective breeding programs.
 
</p></abstract><kwd-group><kwd>&lt;i&gt;Bubalus bubalis&lt;/i&gt;</kwd><kwd> Feed Efficiency</kwd><kwd> Residual Feed Intake</kwd><kwd> Blood Transcriptome</kwd><kwd> Differentially Expressed Genes</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Feed cost contributes to more than 80% of the total maintenance cost in large animals [<xref ref-type="bibr" rid="scirp.124682-ref1">1</xref>] and Residual feed intake (RFI) [<xref ref-type="bibr" rid="scirp.124682-ref1">1</xref>] is determined as the difference between the actual and predicted feed intake [<xref ref-type="bibr" rid="scirp.124682-ref2">2</xref>] , and also defined as the feed conversion efficiency (FCE) in cattle and buffalo [<xref ref-type="bibr" rid="scirp.124682-ref3">3</xref>] . Low RFI heifers end up with additional genetic gain and profitability by reducing 10% to 14% feed consumption, i.e., cutting short on input cost [<xref ref-type="bibr" rid="scirp.124682-ref4">4</xref>] on achieving a comparable growth rate as of high RFI counterparts. RFI has been used as a promising tool to identify feed efficient animals [<xref ref-type="bibr" rid="scirp.124682-ref5">5</xref>] , however, reports in buffaloes are scanty. Feed efficiency trait heritability is determined as 0.01 - 0.3 [<xref ref-type="bibr" rid="scirp.124682-ref1">1</xref>] and is improvable through genetic selection [<xref ref-type="bibr" rid="scirp.124682-ref6">6</xref>] . Variation in RFI has been reported ranging between (−0.20) and high (+0.18) in growing calves [<xref ref-type="bibr" rid="scirp.124682-ref3">3</xref>] and Murrah heifers [<xref ref-type="bibr" rid="scirp.124682-ref7">7</xref>] . Feed intake, nutrient partitioning, immune function and metabolic adaptation in different body tissues are the factors known for influencing feed utilization in animals. A reduction in dry matter intake without compromising the weight gain is expected to improve the overall productivity of animal. Recording of feed intake for an individual animal is arduous and biological markers have been reported (Sikka et al., 2020 [<xref ref-type="bibr" rid="scirp.124682-ref7">7</xref>] ; Baban et al., 2021 [<xref ref-type="bibr" rid="scirp.124682-ref8">8</xref>] ) in calves to enable marker-based selection of feed efficient calves. However, the identification of variants in this respect remains a challenge [<xref ref-type="bibr" rid="scirp.124682-ref8">8</xref>] for employing genomic selection for this trait. The present study is conducted with the aim of determining differentially expressed genes (DEGs) and comparing high and low feed utilizing heifers. Transcriptomic data was collected from low and high RFI heifers using whole blood. The study catalogued the functional genes that were differentially expressed between high and low RFI young buffalo heifers.</p></sec><sec id="s2"><title>2. Material and Methods</title><sec id="s2_1"><title>2.1. Study Location, Animals and Sample Collection</title><p>Animal experiments were performed under approval and review by the Institutional Animal Ethics Committee (IAEC) at ICAR-Central Institute for Research on Buffaloes Hisar, Govt. of India. Heifers of 9 to 11 months age were subjected to control feeding in order to record individual dry matter intake (DMI) to determine residual feed intake (RFI) by estimating the difference between predicted and actual DMI for an individual animal. Dietary regimen of heifers included Jowar fodder and concentrate mixture. Nutrient value of feed was determined using standard methods. Chemical composition and nutrient digestibility of feed<sup> </sup>(g/kg) and nutritive value of diet were determined by reference methods.</p><p>Nutrient digestibility (Mean &#177; SE) of dry matter was 60.4 &#177; 2.43. Percentage of crude protein (CP), digestible crude protein (DCP) and total digestible nutrients (TDN) was determined as 14.2 &#177; 0.13, 12.5 &#177; 0.33 and 61.2 &#177; 1.77, respectively. Blood biochemical profiling revealed IGF1 and Glucose as significant biological attributes related to RFI efficiency in heifers [<xref ref-type="bibr" rid="scirp.124682-ref8">8</xref>] .</p><p><sup>a</sup>Values represent hex plicate assays of each material; <sup>b</sup>Ingredient composition of concentrate mixture: [maize grain, 175 g/kg; barley grain, 175 g/kg; wheat bran, 270 g/kg; mustard cake, 200 g/kg; cotton seed cake, 150 g/kg; mineral mixture, 20 g/kg; common salt, 10 g/kg].</p><p>Daily feed intake and fortnightly body weight were recorded for heifers during the period of 78 days feeding trial. Average DMI (Kg/h/d) and daily weight gain (ADG) were determined. Average BW was attained as 200 Kg in heifers after 78 days of feed trial initiating from 155 Kg. Mean ADG and DMI per animal was recorded as 577 g/h/d and 4.8 kg/day, respectively (<xref ref-type="table" rid="table1">Table 1</xref>). Variation in daily weight gain and DMI was recorded ranging from 382 to 897 g/day and 3.3 to 6.0 kg/d over the 42 heifers during the trial. Mean DMI was regressed with RFI at (R<sup>2</sup> 0.970) in the range of 0.359381 to −0.43778 at high and low extremes (<xref ref-type="fig" rid="fig1">Figure 1</xref>). DMI was recorded as 2.41 Kg lesser in efficient feed conversant group of heifers (low RFI) as compared with less efficient (high RFI). BW gain in these heifers was recorded as 614.84 g/h/d. Low RFI heifers gained 16.4% higher BW through lesser DMI by 13.53% (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><p>A large variation in DMI per unit BW gain over was determined in heifers (n = 42) allocated to low and high RFI feed efficiency (<xref ref-type="table" rid="table1">Table 1</xref>). DGEs in respect of FCE were identified in heifers comparing transcriptomic data obtained from high and low extremes of RFI efficient heifers through high throughput (HTP) sequencing.</p></sec><sec id="s2_2"><title>2.2. RNA Extraction, cDNA Library Preparation and Sequencing</title><p>Total RNA from blood cells collected through veni-puncture was extracted from</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Quality check statistics for RFI transcriptome in buffalo heifers</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Phenotype</th><th align="center" valign="middle" >RFI’S status</th><th align="center" valign="middle" >Raw Reads</th><th align="center" valign="middle" >HQ Reads</th><th align="center" valign="middle" >% HQ Reads</th><th align="center" valign="middle" >(G + C) %</th><th align="center" valign="middle"  colspan="2"  >Alignment</th></tr></thead><tr><td align="center" valign="middle" >FC</td><td align="center" valign="middle" >High</td><td align="center" valign="middle" >48,664,166</td><td align="center" valign="middle" >44,699,558</td><td align="center" valign="middle" >91.85%</td><td align="center" valign="middle" >47.55%</td><td align="center" valign="middle"  colspan="2"  >66.4%</td></tr><tr><td align="center" valign="middle" >FC</td><td align="center" valign="middle" >High</td><td align="center" valign="middle" >48,332,276</td><td align="center" valign="middle" >44,471,050</td><td align="center" valign="middle" >92.01%</td><td align="center" valign="middle" >46.89%</td><td align="center" valign="middle" >64.1%</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >FC</td><td align="center" valign="middle" >Low</td><td align="center" valign="middle" >54,815,212</td><td align="center" valign="middle" >49,764,930</td><td align="center" valign="middle" >90.79%</td><td align="center" valign="middle" >47.20%</td><td align="center" valign="middle" >67.7%</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >FC</td><td align="center" valign="middle" >Low</td><td align="center" valign="middle" >49,083,064</td><td align="center" valign="middle" >44,708,886</td><td align="center" valign="middle" >91.09%</td><td align="center" valign="middle" >46.44%</td><td align="center" valign="middle" >64.3%</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>four heifers (two showing high RFI and two showing low RFI). 1 μg of intact RNA having integrity number (RIN) of 8.0 (Agilent 2100 Bio analyzer) was used to purify mRNA using oligo-dT beads (TruSeq RNA Sample Preparation Kit, Illumina) for each sample. cDNA library preparation and paired-end sequencing were done using denatured (90˚C) mRNA. The RNA fragments were reverse transcribed using random hexamers and Superscript II Reverse Transcriptase (Life Technologies). Second strand cDNA was synthesized on this first strand template, using RNaseH and DNA polymerase I. Clean cDNAs were obtained using Beckman Coulter Agencourt Ampure XP SPRI beads after end-repair and the addition of an “A” base. The clean cDNA molecules were ligated with Illumina adapters. Further, the cDNA library was amplified using PCR for the enrichment of the adapter-ligated fragments. The individual libraries were quantified using NanoDrop spectrophotometer (Thermo Scientific) and validated for quality by Bio analyzer (Agilent Technologies) for subsequent sequencing, using the Illumina HiSeq 2500 platform. Paired-end FASTQ files were subjected to standard quality control. High quality (HQ) filtered reads (Phred scores &gt; 20) were selected using the NGSQC Tool Kit [<xref ref-type="bibr" rid="scirp.124682-ref9">9</xref>] .</p></sec><sec id="s2_3"><title>2.3. Assembly, Annotation and Global Expression Profiling</title><p>RNA extracted from blood of the four heifers (Bubalus bubalis), covering extremely high and low RFI efficiency as estimated based on DMI/h/g BW gain as FCE1:FCE2: vs FCE3:FCE4 was subjected to standard paired end RNA-Seq library(s) preparation as per Illumina recommended protocol using 100 bp paired-end module. Approximately 40 - 60 million paired end sequence reads (Phred score &gt; Q30) were obtained for each library and the same were subjected to stringent quality test using NGSQC tool kit [<xref ref-type="bibr" rid="scirp.124682-ref9">9</xref>] .</p><p>The improved transcripts resulting from the trans-assembly were subjected to the CD-HIT EST clustering pipeline. Redundant transcripts were removed and reference unigene transcriptome was generated from each library, all converging finally into a single non-redundant resultant transcriptome assembly by merging and clustering the transcripts from individual libraries. Resultant transcriptome assembly was aligned with the reference genome sequence, using Bowtie tool for quantification of expressed transcripts. Read count for each transcript was further normalized to determine value of RPKM. Transcripts with an RPKM of ≥1 were categorized as expressed transcript. Treatment specific transcripts were annotated with Gene Ontology and Pathways identified from expressed transcripts by DAVID Functional Annotation Tool [DAVID Bioinformatics Resources 6.8, NIAID/NIH [<xref ref-type="bibr" rid="scirp.124682-ref10">10</xref>] .</p></sec><sec id="s2_4"><title>2.4. RNASeq Data Analysis</title><p>The Reference genome of Bubalus bubalis (https://www.ncbi.nlm.nih.gov/assembly/GCF_003121395.1) was used for read alignment and identification of transcripts coding regions using Kallisto followed by quantification and annotation [<xref ref-type="bibr" rid="scirp.124682-ref11">11</xref>] . Differentially expressed (DE) transcripts (fold-change ≥ 2.0, P-value &lt; 0.05) were identified by DESEQ2 [<xref ref-type="bibr" rid="scirp.124682-ref12">12</xref>] which revealed underlying genetic make-up of efficient RFI, compared with high RFI as control.</p></sec><sec id="s2_5"><title>2.5. Biological Pathways and Gene Ontology Analysis</title><p>The molecular functions, biological mechanisms and gene networks that emerged from the transcripts which were over-represented were determined. Dataset containing gene identifiers, corresponding expression and P-values were uploaded into IPA. Identification of de-regulated genes was done based on significant P-adj value (P &lt; 0.05). The “focus” genes were overlaid onto a global molecular network using Cytoscape software [<xref ref-type="bibr" rid="scirp.124682-ref13">13</xref>] to lineate bio-molecular interaction networks into a unified conceptual framework by evaluating a score ranking the network obtained according to their degree of relevance to the eligible molecules in the dataset. The score is the result of the number of knowledge base considerations of the network eligible molecules into account out of the total number of network eligible molecules that emerged and the total number of possible molecules to be included in the network.</p><p>Ethics Approval: The protocols followed in the present animal study were reviewed and approved by the Institute Animal Ethics Committee (IAEC) of CIRB Hisar. India (Reg. No. 406/GO/RBI/L/01/CPCSEA).</p></sec></sec><sec id="s3"><title>3. Results and Discussion</title><sec id="s3_1"><title>3.1. Sequencing and Mapping Statistics Summary</title><p>An average of 51.9 million (varying between 36.9 - 72 million) paired end raw RNA Seq reads were obtained per sample using Illumina HiSeq platform. Average size of reads qualifying for all the QC criteria was 210 bp (<xref ref-type="table" rid="table1">Table 1</xref>). FASTQ sequences were filtered using NGSQC tool kit thus, an average of 52 million high quality reads per sample (~92.7%) were accounted for alignment and variant detection analysis. Around 88.7% of the HQ reads of created assembly were mapped on the human reference genome using KALLISTO pipeline, which confirms optimum alignment (<xref ref-type="fig" rid="fig2">Figure 2</xref>) of the two genomes.</p></sec><sec id="s3_2"><title>3.2. Transcripts Expression in High and Low RFI Heifers</title><p>Per sample high quality reads obtained from all the heifers were comparable covering nearly 9% of the total reads and having average GC content of 47.22% (<xref ref-type="table" rid="table1">Table 1</xref>).</p><p>RNAseq dataset obtained from selected heifers were evaluated for DEGs including 49781 significant transcripts (Padj = 2.44995163703878E-54 to 0.0504821201656885). Percent alignment of reads with reference genome of Bubalus bubalis varied between 64.1% to 67.7% with respect to heifers (<xref ref-type="fig" rid="fig2">Figure 2</xref>) in the study. Differentially expressed (P &lt; 0.05) transcripts were 850. Correlation matrix coefficients were determined as 0.821*** between replicates of high RFI, i.e. FCE1:FCE2 and 0.967*** between replicates in low RFI individuals i.e. FCE3: FCE4 (<xref ref-type="table" rid="table2">Table 2</xref>). It indicates high similarity in genetic make-up underlying the selected heifers as per the estimated RFI efficiency. Correlation coefficients while regressing the transcript data across high and low RFI category of heifers was significantly low (r<sup>2</sup> 0.851***) for FC1:FC3 and FC2:FC4 (r<sup>2</sup> = 0.816***) while comparing within high or low RFI.</p><p>RFI of an individual heifer is influenced by digestibility, tissue metabolism and protein turnover [<xref ref-type="bibr" rid="scirp.124682-ref14">14</xref>] under the changing patterns in environmental stress, thermoregulation, heat increment, and body composition [<xref ref-type="bibr" rid="scirp.124682-ref15">15</xref>] while evaluating RFI efficiency having uniform feeding regimen.</p></sec><sec id="s3_3"><title>3.3. Differential Expression of Transcripts</title><p>Distinctive pattern of transcripts expression is depicted through Heatmaps (<xref ref-type="fig" rid="fig3">Figure 3</xref>(a) and <xref ref-type="fig" rid="fig3">Figure 3</xref>(b)) generated from high and low RFI efficient heifers. De-regulated genes (P-adjusted &lt; 0.05) are presented as fold change value (&gt;2 or &lt;−2) expressing variation in RFI (<xref ref-type="table" rid="table2">Table 2</xref> and <xref ref-type="table" rid="table3">Table 3</xref>). A total of 850 DEGs (p &lt; 0.05) were detected based on the Cuffdiff analysis (FDR = 0.00174998654944857 to 58.5661012869287 (FDR &lt; 0.05). 427 genes were down-regulated and 420 genes were up-regulated in the study, where top thirty genes in each category of deregulation are shown in <xref ref-type="table" rid="table2">Table 2</xref> and <xref ref-type="table" rid="table3">Table 3</xref>.</p><sec id="s3_3_1"><title>3.3.1. Total 850</title><p>DEGs were identified from 49,781 transcripts, while comparing transcriptomic data obtained from high RFI, ranging between 0.26711 to 0.359381 and low RFI (−0.43778 to −0.20372) category of heifer. The top DEGs are mostly annotated under the Biological processes (&gt;25.08%), Cellular component (21.67%) or Molecular function (20.64%) (<xref ref-type="fig" rid="fig5">Figure 5</xref>) of the GO terms (P 1.31569713353195E−06 to 0.0598850395935369) reported in <xref ref-type="table" rid="table4">Table 4</xref>.</p><p>Down and Up-Regulated DEGs in Relation to RFI</p><p>Top down-regulated genes (Padj &lt; 0.05) out of 421 down-regulated genes related to RFI (low efficiency) are discussed as given in <xref ref-type="table" rid="table2">Table 2</xref>. Cell growth regulator (earlier reports annotated by GO terms related to cell cycle (negative regulation of cell growth, negative regulation of chromosome condensation, telomeric heterochromatin assembly, negative regulation of G0 to G1 transition), Ring finger Protein 213 and E3 ubiquitin-protein ligase gene related to adaptive immunity were emerged as least fold change (log<sub>2</sub>FoldChange = −11.535) and cell signaling (endocytosis) inducing Pleckstrin homology domain containing A2</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Top (adj p &lt; 0.05) down-regulated genes in relation to Residual Feed Intake (RFI) in Murrah Heifers</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >id</th><th align="center" valign="middle" >GENE NAME (SYMBOL)</th><th align="center" valign="middle" >log<sub>2</sub>FoldChange</th><th align="center" valign="middle" >Pval</th><th align="center" valign="middle" >Padj</th><th align="center" valign="middle" >GO Terms/KEGG Pathways</th></tr></thead><tr><td align="center" valign="middle" >XM_025279661.1</td><td align="center" valign="middle" >ring finger protein 213-like (LOC512869)</td><td align="center" valign="middle" >−11.5358814</td><td align="center" valign="middle" >4.35E−47</td><td align="center" valign="middle" >1.08E−42</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >XM_025281101.1</td><td align="center" valign="middle" >C-C motif chemokine 23 (LOC508666)</td><td align="center" valign="middle" >−7.78343054</td><td align="center" valign="middle" >2.17E−38</td><td align="center" valign="middle" >1.80E−34</td><td align="center" valign="middle" >bta04062</td></tr><tr><td align="center" valign="middle" >XM_006075241.2</td><td align="center" valign="middle" >ribosomal protein L17 (RPL17)</td><td align="center" valign="middle" >−5.1856476</td><td align="center" valign="middle" >5.74E−23</td><td align="center" valign="middle" >3.17E−19</td><td align="center" valign="middle" >bta03010</td></tr><tr><td align="center" valign="middle" >XM_006077123.2</td><td align="center" valign="middle" >septin 2 (SEPTIN2)</td><td align="center" valign="middle" >−5.5496903</td><td align="center" valign="middle" >2.83E−18</td><td align="center" valign="middle" >1.28E−14</td><td align="center" valign="middle" >BP-GO:0007224, GO:0007283, GO:0030154, GO:0060271</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >ribosomal protein S15a (RPS15A)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >CC-GO:0000777, GO:0005634, GO:0005737, GO:0005819, GO:0005930,</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >interferon induced protein 44 like (IFI44L)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >CC-GO:0005938, GO:0030496, GO:0032154, GO:0032391, GO:0060170, GO:0097227</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >activity dependent neuroprotector homeobox (ADNP)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >MF-GO:0005525</td></tr><tr><td align="center" valign="middle" >XM_006047001.2</td><td align="center" valign="middle" >2’,5’-oligoadenylate synthetase 1, 40/46kDa (OAS1Z)</td><td align="center" valign="middle" >−4.74740379</td><td align="center" valign="middle" >5.29E−16</td><td align="center" valign="middle" >2.03E−12</td><td align="center" valign="middle" >GO:0006412(BP); bta03010</td></tr><tr><td align="center" valign="middle" >XM_025288393.1</td><td align="center" valign="middle" >uncharacterized LOC509649 (MGC139164)</td><td align="center" valign="middle" >−4.28569569</td><td align="center" valign="middle" >1.22E−14</td><td align="center" valign="middle" >3.20E−11</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >XM_025267539.1</td><td align="center" valign="middle" >ribosomal protein lateral stalk subunit P1 (RPLP1)</td><td align="center" valign="middle" >−3.6517848</td><td align="center" valign="middle" >5.74E−14</td><td align="center" valign="middle" >1.34E−10</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >XM_025263281.1</td><td align="center" valign="middle" >zinc finger CCCH-type containing 11A (ZC3H11A)</td><td align="center" valign="middle" >−9.33270472</td><td align="center" valign="middle" >5.91E−14</td><td align="center" valign="middle" >1.34E−10</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >XM_025269545.1</td><td align="center" valign="middle" >zinc finger CCCH-type containing 7A (ZC3H7A)</td><td align="center" valign="middle" >−7.23658998</td><td align="center" valign="middle" >4.17E−12</td><td align="center" valign="middle" >5.77E−09</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >XM_006060462.2</td><td align="center" valign="middle" >BUB3 mitotic checkpoint protein (BUB3)</td><td align="center" valign="middle" >−3.54542484</td><td align="center" valign="middle" >6.03E−12</td><td align="center" valign="middle" >8.11E−09</td><td align="center" valign="middle" >BP-GO:0006414, GO:0032147 bta03010</td></tr><tr><td align="center" valign="middle" >XM_025277657.1</td><td align="center" valign="middle" >sterile alpha motif domain containing 9 (SAMD9)</td><td align="center" valign="middle" >−4.61121636</td><td align="center" valign="middle" >1.52E−11</td><td align="center" valign="middle" >1.80E−08</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >XM_025275327.1</td><td align="center" valign="middle" >trappin 5 (LOC407163)</td><td align="center" valign="middle" >−5.91966321</td><td align="center" valign="middle" >1.93E−11</td><td align="center" valign="middle" >2.24E−08</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >XM_006080412.2</td><td align="center" valign="middle" >docosahexaenoic acid omega-hydroxylase CYP4F3 (LOC100295883)</td><td align="center" valign="middle" >−5.30250301</td><td align="center" valign="middle" >3.24E−11</td><td align="center" valign="middle" >3.67E−08</td><td align="center" valign="middle" >BP-GO:0000070, GO:0008608, GO:0034501, GO:0051301, GO:0051321, GO:0051983</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >lipopolysaccharide-binding protein (LOC514978)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >CC-GO:0000777, GO:0005654 bta04110</td></tr><tr><td align="center" valign="middle" >XM_025290852.1</td><td align="center" valign="middle" >ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 (ARAP1)</td><td align="center" valign="middle" >−3.27255752</td><td align="center" valign="middle" >7.85E−11</td><td align="center" valign="middle" >8.26E−08</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >XM_025277561.1</td><td align="center" valign="middle" >MHC class I heavy chain (BOLA)</td><td align="center" valign="middle" >−4.38948037</td><td align="center" valign="middle" >1.00E−10</td><td align="center" valign="middle" >1.02E−07</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >XM_006072394.2</td><td align="center" valign="middle" >histone cluster 1, H2ak (HIST1H2AK)</td><td align="center" valign="middle" >−5.01974918</td><td align="center" valign="middle" >1.78E−10</td><td align="center" valign="middle" >1.70E−07</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >XM_006047679.2</td><td align="center" valign="middle" >5-hydroxymethylcytosine binding, ES cell specific (HMCES)</td><td align="center" valign="middle" >−5.55588498</td><td align="center" valign="middle" >3.91E−10</td><td align="center" valign="middle" >3.47E−07</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >XM_025263480.1</td><td align="center" valign="middle" >tetratricopeptide repeat domain 17 (TTC17)</td><td align="center" valign="middle" >−4.07575794</td><td align="center" valign="middle" >5.09E−09</td><td align="center" valign="middle" >3.38E−06</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >XM_025265768.1</td><td align="center" valign="middle" >microtubule associated serine/threonine kinase 3 (MAST3)</td><td align="center" valign="middle" >−7.59548873</td><td align="center" valign="middle" >1.00E−08</td><td align="center" valign="middle" >6.47E−06</td><td align="center" valign="middle" >bta04144</td></tr><tr><td align="center" valign="middle" >XM_025260666.1</td><td align="center" valign="middle" >regulator of G protein signaling 14 (RGS14)</td><td align="center" valign="middle" >−2.89345459</td><td align="center" valign="middle" >1.12E−08</td><td align="center" valign="middle" >6.78E−06</td><td align="center" valign="middle" >bta04144, bta04145, bta04514, bta04612, bta04940, bta05320, bta05330, bta05332, bta05416</td></tr><tr><td align="center" valign="middle" >XM_025287947.1</td><td align="center" valign="middle" >dipeptidyl peptidase 8 (DPP8)</td><td align="center" valign="middle" >−8.47054961</td><td align="center" valign="middle" >1.13E−08</td><td align="center" valign="middle" >6.78E−06</td><td align="center" valign="middle" >bta05322</td></tr><tr><td align="center" valign="middle" >XR_003105652.1</td><td align="center" valign="middle" >heterogeneous nuclear ribonucleoprotein A2/B1 (HNRNPA2B1)</td><td align="center" valign="middle" >−6.68318896</td><td align="center" valign="middle" >2.21E−08</td><td align="center" valign="middle" >1.21E−05</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >XM_025266200.1</td><td align="center" valign="middle" >putative ISG12(a) protein (IFI27)</td><td align="center" valign="middle" >−8.3225372</td><td align="center" valign="middle" >2.60E−08</td><td align="center" valign="middle" >1.36E−05</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >XM_025293848.1</td><td align="center" valign="middle" >zinc finger protein 436 (ZNF436)</td><td align="center" valign="middle" >−3.73897337</td><td align="center" valign="middle" >3.75E−08</td><td align="center" valign="middle" >1.92E−05</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >XM_025292941.1</td><td align="center" valign="middle" >pleckstrin homology domain containing A2 (PLEKHA2)</td><td align="center" valign="middle" >−5.51504062</td><td align="center" valign="middle" >4.13E−08</td><td align="center" valign="middle" >2.07E−05</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >XM_025296315.1</td><td align="center" valign="middle" >thyroid hormone receptor interactor 12 (TRIP12)</td><td align="center" valign="middle" >−2.81119621</td><td align="center" valign="middle" >4.97E−08</td><td align="center" valign="middle" >2.35E−05</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >XM_006045746.2</td><td align="center" valign="middle" >ring finger protein 144A (RNF144A)</td><td align="center" valign="middle" >−8.24002619</td><td align="center" valign="middle" >5.81E−08</td><td align="center" valign="middle" >2.70E−05</td><td align="center" valign="middle" >GO:0000398, GO:0006406, GO:0031053, GO:1990428</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Bubalus bubalis CD274 molecule (CD274)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >GO:0005634, GO:0005654, GO:0005737, GO:0070062, GO:0071013, GO:1990904</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >arginyltransferase 1 (ATE1)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >GO:0003730, GO:0035198, GO:0043047, GO:1990247</td></tr><tr><td align="center" valign="middle" >XM_006060747.2</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >−2.6878571</td><td align="center" valign="middle" >8.31E−08</td><td align="center" valign="middle" >3.66E−05</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >XM_006056562.2</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >−7.39788877</td><td align="center" valign="middle" >8.84E−08</td><td align="center" valign="middle" >3.79E−05</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >XM_025278285.1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >−2.46165621</td><td align="center" valign="middle" >1.18E−07</td><td align="center" valign="middle" >4.77E−05</td><td align="center" valign="middle" >CC-GO:0005634, GO:0005886 MF-GO:0043325</td></tr><tr><td align="center" valign="middle" >XM_025278388.1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >−4.17188819</td><td align="center" valign="middle" >2.40E−07</td><td align="center" valign="middle" >8.72E−05</td><td align="center" valign="middle" >GO:0006281, GO:0006511, GO:0006974, GO:0016567, GO:0045995, GO:1901315, GO:2000780</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >CC-GO:0005654, MF-GO:0004842, GO:0046966 bta04120</td></tr></tbody></table></table-wrap><p>gene showing maximum change (log2 FoldChange = −2.461) for down-regulation in efficient feed conversant(low RFI) heifers in comparison to less efficient heifers (high RFI) in this study.</p><p>Down-regulated Pleckstrin homology domain containing A2, an endocytsis &amp; cell signalling [PLEKHA2]gene, Ring finger protein 213-like [ATPase, adaptive Immunity] [LOC512869], IFI27, Dipeptidyl peptidase 8 [blocking T-cell activation and immune, MHC class I heavy chain, Sterile alpha motif domain containing 9 [TNF-alpha signalling] and Lipopolysaccharide-binding protein [Gm –ve bacterial infections] genes fighting out the gram negative bacterial infection.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Top (adjp &lt; 0.05) Up-regulated genes in relation to Residual Feed Intake (RFI) in Murraj Heifers</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >id</th><th align="center" valign="middle" >GENE NAME (SYMBOL)</th><th align="center" valign="middle" >log<sub>2</sub>FoldChange</th><th align="center" valign="middle" >Pval</th><th align="center" valign="middle" >Padj</th><th align="center" valign="middle" >G O Term/KEGG PATWAY</th></tr></thead><tr><td align="center" valign="middle" >XM_006040113.2</td><td align="center" valign="middle" >ribosomal protein L26 (RPL26)</td><td align="center" valign="middle" >9.372519</td><td align="center" valign="middle" >7.08E−45</td><td align="center" valign="middle" >8.82E−41</td><td align="center" valign="middle" >BP-GO:06364, GO:0006977, GO:0045727, GO:71480, GO:1902164, GO:1902167, GO:1904803 CC-GO:05654, GO:0005730 MF-GO:0048027bta03010</td></tr><tr><td align="center" valign="middle" >XM_006068498.2</td><td align="center" valign="middle" >uncharacterized LOC509649 (MGC139164)</td><td align="center" valign="middle" >8.87757</td><td align="center" valign="middle" >6.47E−27</td><td align="center" valign="middle" >4.60E−23</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >XM_006079472.2</td><td align="center" valign="middle" >nuclear receptor corepressor 1 (NCOR1)</td><td align="center" valign="middle" >9.476325</td><td align="center" valign="middle" >3.24E−15</td><td align="center" valign="middle" >1.01E−11</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >XM_025263095.1</td><td align="center" valign="middle" >multidrug resistance-associated protein 4 (LOC523126)</td><td align="center" valign="middle" >5.25911</td><td align="center" valign="middle" >6.96E−15</td><td align="center" valign="middle" >1.92E−11</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >XM_025276766.1</td><td align="center" valign="middle" >solute carrier family 9 member A7 (SLC9A7)</td><td align="center" valign="middle" >6.406896</td><td align="center" valign="middle" >3.90E−14</td><td align="center" valign="middle" >9.72E−11</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >XM_025290227.1</td><td align="center" valign="middle" >recombination signal binding protein for immunoglobulin kappa J region(RBPJ)</td><td align="center" valign="middle" >9.263303</td><td align="center" valign="middle" >1.24E−13</td><td align="center" valign="middle" >2.47E−10</td><td align="center" valign="middle" >BP-GO:0007221, GO:0061419 CC-GO:0005634, GO:0005737 MF-GO:0000978, GO:0001228, GO:0008134, GO:0043565 bta04330</td></tr><tr><td align="center" valign="middle" >XM_006056244.2</td><td align="center" valign="middle" >ATPase secretory pathway Ca<sup>2+</sup> transporting 1 (ATP2C1)</td><td align="center" valign="middle" >9.237406</td><td align="center" valign="middle" >1.95E−13</td><td align="center" valign="middle" >3.74E−10</td><td align="center" valign="middle" >BP-GO:06816, GO:06828, GO:06874, GO:0008544, GO:0016339, GO:030026, GO:0031532, GO:0032468, GO:0032472, GO:043123, GO:00714 CC-GO:00139, GO:05794, GO:005802, GO:0016021 MF-GO:05388, GO:05509, GO:05524, GO:0015410, GO:0030145</td></tr><tr><td align="center" valign="middle" >XM_025290188.1</td><td align="center" valign="middle" >glutamate dehydrogenase 1 (GLUD1)</td><td align="center" valign="middle" >6.977029</td><td align="center" valign="middle" >2.88E−13</td><td align="center" valign="middle" >5.31E−10</td><td align="center" valign="middle" >BP-GO:06538, GO:06541, GO:0055114, GO:0072350 CC-GO:005739, GO:05743, GO:05759 MF-GO:04352, GO:04353, GO:05524, GO:05525, GO:042802 bta00250, bta00330, bta00471, bta00910, bta01100, bta04964</td></tr><tr><td align="center" valign="middle" >XM_025279441.1</td><td align="center" valign="middle" >Bubalus bubalis CMRF35-like molecule 6 (LOC102401307)</td><td align="center" valign="middle" >5.621436</td><td align="center" valign="middle" >3.70E−13</td><td align="center" valign="middle" >6.35E−10</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >XR_003106834.1</td><td align="center" valign="middle" >Bubalus bubalis uncharacterized LOC102399157 (LOC102399157)</td><td align="center" valign="middle" >6.205958</td><td align="center" valign="middle" >1.34E−12</td><td align="center" valign="middle" >1.96E−09</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >XR_003107078.1</td><td align="center" valign="middle" >UL16-binding protein 3-like (LOC101903261)</td><td align="center" valign="middle" >4.461226</td><td align="center" valign="middle" >6.78E−11</td><td align="center" valign="middle" >7.33E−08</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >XM_006070557.2</td><td align="center" valign="middle" >exportin 6 (XPO6)</td><td align="center" valign="middle" >3.538839</td><td align="center" valign="middle" >7.96E−11</td><td align="center" valign="middle" >8.26E−08</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >XM_025292145.1</td><td align="center" valign="middle" >solute carrier family 25 member 46 (SLC25A46)</td><td align="center" valign="middle" >8.777975</td><td align="center" valign="middle" >1.40E−10</td><td align="center" valign="middle" >1.37E−07</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >XM_025280828.1</td><td align="center" valign="middle" >ankyrin repeat and FYVE domain containing 1 (ANKFY1)</td><td align="center" valign="middle" >4.795866</td><td align="center" valign="middle" >4.05E−10</td><td align="center" valign="middle" >3.54E−07</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >XM_025285338.1</td><td align="center" valign="middle" >CD46 molecule (CD46)</td><td align="center" valign="middle" >7.31271</td><td align="center" valign="middle" >4.92E−10</td><td align="center" valign="middle" >4.15E−07</td><td align="center" valign="middle" >BP-GO:06958, GO:07338, GO:0045087 CC-GO:02079, GO:09986, GO:0016021 bta04610</td></tr><tr><td align="center" valign="middle" >XM_025263119.1</td><td align="center" valign="middle" >multidrug resistance-associated protein 4-like (LOC100848700)</td><td align="center" valign="middle" >2.943814</td><td align="center" valign="middle" >7.27E−10</td><td align="center" valign="middle" >5.74E−07</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >XM_006066222.2</td><td align="center" valign="middle" >MAX dimerization protein MGA (MGA)</td><td align="center" valign="middle" >4.051975</td><td align="center" valign="middle" >1.41E−09</td><td align="center" valign="middle" >1.08E−06</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >XM_025293679.1</td><td align="center" valign="middle" >adhesion G protein-coupled receptor E2 (LOC100337213)</td><td align="center" valign="middle" >2.859846</td><td align="center" valign="middle" >1.69E−09</td><td align="center" valign="middle" >1.25E−06</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >XM_025277596.1</td><td align="center" valign="middle" >multidrug resistance-associated protein 4-like (LOC522174)</td><td align="center" valign="middle" >5.736846</td><td align="center" valign="middle" >1.71E−09</td><td align="center" valign="middle" >1.25E−06</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >XM_006078588.2</td><td align="center" valign="middle" >ubiquitin specific peptidase like 1 (USPL1)</td><td align="center" valign="middle" >3.966731</td><td align="center" valign="middle" >3.19E−09</td><td align="center" valign="middle" >2.23E−06</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >XM_025263377.1</td><td align="center" valign="middle" >spleen trypsin inhibitor (LOC404103)</td><td align="center" valign="middle" >3.836132</td><td align="center" valign="middle" >3.99E−09</td><td align="center" valign="middle" >2.72E−06</td><td align="center" valign="middle" >BP-GO:0010951</td></tr><tr><td align="center" valign="middle" >XM_025265374.1</td><td align="center" valign="middle" >Bubalus bubalis neutral sphingomyelinase activation associated factor (NSMAF)</td><td align="center" valign="middle" >4.019168</td><td align="center" valign="middle" >1.20E−08</td><td align="center" valign="middle" >7.00E−06</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >XM_025280030.1</td><td align="center" valign="middle" >histone deacetylase 5 (HDAC5)</td><td align="center" valign="middle" >8.398223</td><td align="center" valign="middle" >1.44E−08</td><td align="center" valign="middle" >8.16E−06</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >XM_025285538.1</td><td align="center" valign="middle" >Bubalus bubalis torsin 1A interacting protein 1 (TOR1AIP1)</td><td align="center" valign="middle" >8.407368</td><td align="center" valign="middle" >1.66E−08</td><td align="center" valign="middle" >9.29E−06</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >XM_006047611.2</td><td align="center" valign="middle" >nuclear factor of activated T cells 5 (NFAT5)</td><td align="center" valign="middle" >2.692906</td><td align="center" valign="middle" >4.55E−08</td><td align="center" valign="middle" >2.20E−05</td><td align="center" valign="middle" >bta04310, bta04360, bta04370, bta04650, bta04660, bta04662</td></tr><tr><td align="center" valign="middle" >XM_025290080.1</td><td align="center" valign="middle" >tec protein tyrosine kinase (TEC)</td><td align="center" valign="middle" >3.21618</td><td align="center" valign="middle" >7.73E−08</td><td align="center" valign="middle" >3.47E−05</td><td align="center" valign="middle" >bta04380, bta04660</td></tr><tr><td align="center" valign="middle" >XM_025270574.1</td><td align="center" valign="middle" >RPTOR independent companion of MTOR complex 2 (RICTOR)</td><td align="center" valign="middle" >8.232591</td><td align="center" valign="middle" >9.20E−08</td><td align="center" valign="middle" >3.91E−05</td><td align="center" valign="middle" >bta04150</td></tr><tr><td align="center" valign="middle" >XM_025277588.1</td><td align="center" valign="middle" >multidrug resistance-associated protein 4-like (LOC101902555)</td><td align="center" valign="middle" >4.224184</td><td align="center" valign="middle" >2.42E−07</td><td align="center" valign="middle" >8.72E−05</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >XM_006049052.2</td><td align="center" valign="middle" >tubulin beta 1 class VI (TUBB1)</td><td align="center" valign="middle" >2.430824</td><td align="center" valign="middle" >2.81E−07</td><td align="center" valign="middle" >9.99E−05</td><td align="center" valign="middle" >bta04145, bta04540</td></tr><tr><td align="center" valign="middle" >XM_025278132.1</td><td align="center" valign="middle" >phosphoinositide kinase, FYVE-type zinc finger containing (PIKFYVE)</td><td align="center" valign="middle" >8.091958</td><td align="center" valign="middle" >4.12E−07</td><td align="center" valign="middle" >0.000139</td><td align="center" valign="middle" >bta00562, bta04070, bta04145, bta04810</td></tr></tbody></table></table-wrap><p>Down-regulation of Thyroid hormone receptor inter actor 12 [Innate Immune System gene associated with presenting Class I MHC mediated antigen and Innate Immune System; IFI44L gene regressing the Interferon stimulating antiviral proteins and CD274 gene, blocking T-cell activation building-up innate immunity and T cell activation for developing feed efficiency in heifers. (RNF144A) ring finger protein 144A promoting ubiquitination, down-regulated transcription regulator genes as (LOC407163) trappin 5 rate of transcription, 5OH methyl cytosine binding, (ES cell specific), zinc finger CCCH-type containing 11a genes having role in n mRNA export were down-regulated expressing the lower rate of chromosome segregation for replication due to down-regulating BUB3 gene and transforming growth factor beta (TGF-β) protein expression consequent upon lower expression of ribosomal protein S15a gene thus, hampering the cell growth</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Gene ontology terms and biological pathways identified from differential genes in high and low residual feed intake efficiency buffalo heifers</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Category</th><th align="center" valign="middle" >Term</th><th align="center" valign="middle" ></th><th align="center" valign="middle" >PValue</th><th align="center" valign="middle" >Genes</th></tr></thead><tr><td align="center" valign="middle" >GOTERM_CC_DIRECT</td><td align="center" valign="middle" >GO:0005654~nucleoplasm</td><td align="center" valign="middle" >65</td><td align="center" valign="middle" >1.32E−06</td><td align="center" valign="middle" >KIF23, XRCC3, PRPF4B, AURKAIP1, IFI44L, FOXO3, MIOS, TIA1, RNF38, PMS2, ATF7IP, SYMPK, SRPK2, CGRRF1, HNRNPA2B1, ARHGAP27, MBNL1, ISG20L2, PARP10, ARID1B, TOX4, ZFR, RPTOR, SLTM, USP28, YME1L1, CLOCK, ADD1, ZNF436, NEK7, IQCB1, PFKFB3, PEAK1, TFE3, ELK3, SCRIB, ECD, NFAT5, BCL9L, MAML3, NDRG2, SNAP23, BUB3, TRIP12, PRPF40A, ZMYM1, KLF12, PPHLN1, PHB, ZMYM5, ILF3, HNRNPDL, STAT3, SFMBT2, COG3, MEF2D, CBLB, SRSF4, NSMF, HNRNPH1</td></tr><tr><td align="center" valign="middle" >KEGG_PATHWAY</td><td align="center" valign="middle" >bta05169:Epstein-Barr virus infection</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >1.65E−06</td><td align="center" valign="middle" >PIK3CG, BOLA, TRAF2, FCER2, MGC126945, STAT3, TYK2, AKT1, MAPK9, PIK3R5, RBPJ, ENTPD1, EIF2AK2</td></tr><tr><td align="center" valign="middle" >KEGG_PATHWAY</td><td align="center" valign="middle" >bta05160:Hepatitis C</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >3.29E−05</td><td align="center" valign="middle" >AKT1, PIK3CG, TYK2, TRAF2, IKBKE, RXRA, MAPK9, PIK3R5, OAS2, EIF2AK2, STAT3, EIF2AK4, NR1H3</td></tr><tr><td align="center" valign="middle" >GOTERM_MF_DIRECT</td><td align="center" valign="middle" >GO:0005524~ATP binding</td><td align="center" valign="middle" >54</td><td align="center" valign="middle" >2.14E−04</td><td align="center" valign="middle" >ABCF1, KIF23, XRCC3, TARS2, ERCC6L2, PRPF4B, STK36, ACSS3, PRKX, AKT1, PMS2, SRPK2, YARS, WNK1, MINK1, LOC100299180, TBCK, CDKL4, MAST3, TYK2, SCYL1, ATP2C1, HIPK2, MAPK9, YME1L1, EIF2AK2, EIF2AK4, NEK7, STK16, PFKFB4, PFKFB3, GLUD1, PEAK1, OAS1Z, TRIB3, CHEK2, OAS2, CHD9, IGF1R, ERCC6, PIKFYVE, LMTK2, CHD6, ENTPD1, TEC, LOC523126, TAOK3, MET, RIMKLA, ATM, IKBKE, LOC522174, NLRP12, JAK2</td></tr><tr><td align="center" valign="middle" >KEGG_PATHWAY</td><td align="center" valign="middle" >bta05168:Herpes simplex infection</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >2.67E−04</td><td align="center" valign="middle" >TRAF1, TYK2, TRAF2, BOLA, IKBKE, SRSF4, MAPK9, JAK2, OAS2, EIF2AK2, MGC126945, EIF2AK4, CLOCK</td></tr><tr><td align="center" valign="middle" >GOTERM_BP_DIRECT</td><td align="center" valign="middle" >GO:0002474~antigen processing and presentation of peptide antigen via MHC class I</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >2.89E−04</td><td align="center" valign="middle" >BOLA</td></tr><tr><td align="center" valign="middle" >GOTERM_CC_DIRECT</td><td align="center" valign="middle" >GO:0042612~MHC class I protein complex</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >2.91E−04</td><td align="center" valign="middle" >BOLA</td></tr><tr><td align="center" valign="middle" >KEGG_PATHWAY</td><td align="center" valign="middle" >bta04152:AMPK signaling pathway</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >2.92E−04</td><td align="center" valign="middle" >AKT1, PIK3CG, IGF1R, PFKFB4, TSC1, PFKFB3, PPP2R5C, PIK3R5, FOXO3, RPTOR, CPT1A</td></tr><tr><td align="center" valign="middle" >GOTERM_BP_DIRECT</td><td align="center" valign="middle" >GO:0090630~activation of GTPase activity</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >0.001115995</td><td align="center" valign="middle" >RALGAPA2, NDEL1, TSC1, TBC1D9, RASGRP1, TBC1D5, SCRIB, TBCK</td></tr><tr><td align="center" valign="middle" >GOTERM_MF_DIRECT</td><td align="center" valign="middle" >GO:0003676~nucleic acid binding</td><td align="center" valign="middle" >26</td><td align="center" valign="middle" >0.001231736</td><td align="center" valign="middle" >RALY, ZKSCAN7, KLF7, ZNF469, ZBTB47, ERCC6L2, SETD1B, ZNF142, EXD2, ZNF655, HNRNPDL, ZNF177, ZNF333, PNLDC1, ZNF32, LOC100124497, ZNF783, ZNF383, THOC7, CELF2, ZNF462, CHD6, ZNF575, ZNF484, ZNF572, ZNF436</td></tr><tr><td align="center" valign="middle" >KEGG_PATHWAY</td><td align="center" valign="middle" >bta05164:Influenza A</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >0.001450005</td><td align="center" valign="middle" >AKT1, TYK2, PIK3CG, IKBKE, NUP98, LOC784541, MAPK9, JAK2, PIK3R5, OAS2, EIF2AK2, EIF2AK4</td></tr><tr><td align="center" valign="middle" >GOTERM_MF_DIRECT</td><td align="center" valign="middle" >GO:0044822~poly(A) RNA binding</td><td align="center" valign="middle" >38</td><td align="center" valign="middle" >0.001518466</td><td align="center" valign="middle" >RALY, ABCF1, BCLAF1, PRPF4B, HMGN2, RPS15A, HELZ, ANKRD17, TIA1, MRPL54, UBAP2L, TNRC6B, FNDC3B, DUS3L, PRPF40A, SRPK2, YARS, ARHGEF1, ZC3H7A, PPHLN1, RBM12B, RPL26, ILF3, ISG20L2, MBNL1, HNRNPDL, ZFR, SLTM, SRSF4, LARP4, LRP1, NCOA5, RPP25L, HNRNPH1, EIF2AK2, ADD1, SUPT6H, GOLGB1</td></tr><tr><td align="center" valign="middle" >KEGG_PATHWAY</td><td align="center" valign="middle" >bta04611:Platelet activation</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >0.001864725</td><td align="center" valign="middle" >AKT1, PIK3CG, ARHGEF1, RASGRP1, PLA2G4F, PIK3R5, SNAP23, ARHGEF12, ITGB1, ITGA2B</td></tr><tr><td align="center" valign="middle" >KEGG_PATHWAY</td><td align="center" valign="middle" >bta04210:Apoptosis</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >0.002292729</td><td align="center" valign="middle" >AKT1, PIK3CG, TRAF2, CASP7, LOC784541, PIK3R5, ATM</td></tr><tr><td align="center" valign="middle" >KEGG_PATHWAY</td><td align="center" valign="middle" >bta04015:Rap1 signaling pathway</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >0.00259339</td><td align="center" valign="middle" >AKT1, PIK3CG, IGF1R, RASGRP3, MRAS, MET, SIPA1L3, PIK3R5, PDGFD, THBS1, ITGB1, RGS14, ITGA2B</td></tr><tr><td align="center" valign="middle" >GOTERM_CC_DIRECT</td><td align="center" valign="middle" >GO:0036064~ciliary basal body</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >0.002743578</td><td align="center" valign="middle" >AKT1, CYLD, WRAP73, KIFAP3, PCM1, WHRN, RTTN, SPATA7</td></tr><tr><td align="center" valign="middle" >GOTERM_MF_DIRECT</td><td align="center" valign="middle" >GO:0005096~GTPase activator activity</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >0.003435645</td><td align="center" valign="middle" >TBC1D9, SIPA1L3, RGS19, OCRL, RIC8B, TBCK, RGS14, RALGAPA2, RASGRP3, RABEP1, STXBP5, TBC1D5, ARHGDIB</td></tr><tr><td align="center" valign="middle" >KEGG_PATHWAY</td><td align="center" valign="middle" >bta04330:Notch signaling pathway</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >0.003519254</td><td align="center" valign="middle" >DTX4, PSEN1, APH1B, NOTCH4, MAML3, RBPJ</td></tr><tr><td align="center" valign="middle" >GOTERM_BP_DIRECT</td><td align="center" valign="middle" >GO:0022027~interkinetic nuclear migration</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >0.004070538</td><td align="center" valign="middle" >CEP120, PCM1, HOOK3</td></tr><tr><td align="center" valign="middle" >GOTERM_BP_DIRECT</td><td align="center" valign="middle" >GO:0016477~cell migration</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >0.004185454</td><td align="center" valign="middle" >TYK2, TNS3, CLN3, NDEL1, PEAK1, JAK2, THBS1, BRAT1, SCRIB, PRPF40A</td></tr><tr><td align="center" valign="middle" >KEGG_PATHWAY</td><td align="center" valign="middle" >bta04920:Adipocytokine signaling pathway</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >0.004542899</td><td align="center" valign="middle" >AKT1, TRAF2, RXRA, MAPK9, JAK2, CPT1A, STAT3</td></tr><tr><td align="center" valign="middle" >GOTERM_BP_DIRECT</td><td align="center" valign="middle" >GO:0006511~ubiquitin-dependent protein catabolic process</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >0.004798544</td><td align="center" valign="middle" >CYLD, USP28, USP40, USP11, USP20, USP37, USP25, USP42, TTC3</td></tr><tr><td align="center" valign="middle" >KEGG_PATHWAY</td><td align="center" valign="middle" >bta04917:Prolactin signaling pathway</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >0.005568078</td><td align="center" valign="middle" >AKT1, PIK3CG, MAPK9, JAK2, PIK3R5, FOXO3, STAT3</td></tr><tr><td align="center" valign="middle" >GOTERM_CC_DIRECT</td><td align="center" valign="middle" >GO:0005813~centrosome</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >0.005605498</td><td align="center" valign="middle" >IQCB1, KIF23, MBNL1, CEP85L, PCM1, RIC8B, RGS14, RTTN, PCGF5, CYLD, ODF2L, G6PD, NDEL1, PSEN1, WRAP73, KIFAP3, USP20, NDRG2</td></tr><tr><td align="center" valign="middle" >GOTERM_CC_DIRECT</td><td align="center" valign="middle" >GO:0005801~cis-Golgi network</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >0.006078583</td><td align="center" valign="middle" >COG3, SCYL1, ANGEL1, GOLGB1, HOOK3</td></tr><tr><td align="center" valign="middle" >GOTERM_BP_DIRECT</td><td align="center" valign="middle" >GO:2000323~negative regulation of glucocorticoid receptor signaling pathway</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >0.006665319</td><td align="center" valign="middle" >CRY2, PHB, CLOCK</td></tr><tr><td align="center" valign="middle" >GOTERM_MF_DIRECT</td><td align="center" valign="middle" >GO:0004843~thiol-dependent ubiquitin-specific protease activity</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >0.008398196</td><td align="center" valign="middle" >CYLD, USP28, USP11, USP20, USP37, USP25, USP42</td></tr><tr><td align="center" valign="middle" >GOTERM_MF_DIRECT</td><td align="center" valign="middle" >GO:0003725~double-stranded RNA binding</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >0.009206343</td><td align="center" valign="middle" >TARBP2, OAS1Z, ILF3, MBNL1, OAS2, EIF2AK2</td></tr><tr><td align="center" valign="middle" >KEGG_PATHWAY</td><td align="center" valign="middle" >bta04380:Osteoclast differentiation</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >0.009224883</td><td align="center" valign="middle" >AKT1, TYK2, PIK3CG, TRAF2, CYLD, MITF, MAPK9, PIK3R5, TEC</td></tr><tr><td align="center" valign="middle" >KEGG_PATHWAY</td><td align="center" valign="middle" >bta04150:mTOR signaling pathway</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >0.009304827</td><td align="center" valign="middle" >AKT1, PIK3CG, TSC1, PIK3R5, RICTOR, RPTOR</td></tr><tr><td align="center" valign="middle" >GOTERM_BP_DIRECT</td><td align="center" valign="middle" >GO:0035455~response to interferon-alpha</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >0.009823125</td><td align="center" valign="middle" >EIF2AK2, MX2, KLHL20</td></tr><tr><td align="center" valign="middle" >KEGG_PATHWAY</td><td align="center" valign="middle" >bta04910:Insulin signaling pathway</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >0.01004313</td><td align="center" valign="middle" >AKT1, PIK3CG, CBLB, SORBS1, TSC1, PPP1R3F, MAPK9, PIK3R5, RPTOR</td></tr><tr><td align="center" valign="middle" >GOTERM_CC_DIRECT</td><td align="center" valign="middle" >GO:0005737~cytoplasm</td><td align="center" valign="middle" >103</td><td align="center" valign="middle" >0.010610664</td><td align="center" valign="middle" >XRCC3, TARS2, HMGN2, METTL21A, XPO6, STK36, SNCA, PRKX, LNX1, TRIM47, LOC515551, RNF38, PMS2, MX2, PIK3CG, YARS, HNRNPA2B1, EXD2, ARID1B, RIC8B, TACC1, TNS3, RALGAPA2, LYST, MGA, CELF2, DCUN1D3, ZNF436, STK16, SETD1B, PEAK1, TFE3, TTC3, SH3BP5L, NDRG2, PRPF40A, ZMYM1, KLF12, ZMYM5, TAOK3, ARFIP1, RIMKLA, ATE1, HDAC5, CBLB, NSMF, SMURF1, RBPJ, HNRNPH1, PLEKHA2, CREBRF, ABCF1, DPH3, AKT1, ANKRD17, RMND5A, CASP7, DPP8, MICAL1, TUBB1, NRG1, KLHL20, ATF7IP, SYMPK, SRPK2, ARHGEF2, EGR2, ARHGEF1, LPGAT1, FBXL20, MINK1, ARHGAP27, KCTD20, ARHGEF12, KLHDC3, TYK2, TARBP2, USP28, HIPK2, THOC7, SIAH1, UBB, TPM3, NDC1, IGF1R, CHD9, ECD, NFAT5, TRIP12, SHMT2, UPF2, USP40, RCAN3, TTC17, BRAT1, STAT3, RGS14, MEF2D, ATXN7, SAMD9, NLRP12, JAK2, RNF111</td></tr><tr><td align="center" valign="middle" >KEGG_PATHWAY</td><td align="center" valign="middle" >bta04931:Insulin resistance</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >0.010979344</td><td align="center" valign="middle" >AKT1, PIK3CG, MAPK9, TRIB3, PIK3R5, CPT1A, STAT3, NR1H3</td></tr><tr><td align="center" valign="middle" >GOTERM_BP_DIRECT</td><td align="center" valign="middle" >GO:0046777~protein autophosphorylation</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >0.012710802</td><td align="center" valign="middle" >STK16, IGF1R, PEAK1, TAOK3, LMTK2, MINK1, CHEK2, EIF2AK2, PRKX</td></tr><tr><td align="center" valign="middle" >GOTERM_BP_DIRECT</td><td align="center" valign="middle" >GO:0070536~protein K63-linked deubiquitination</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >0.013113229</td><td align="center" valign="middle" >CYLD, SHMT2, USP20, USP25</td></tr><tr><td align="center" valign="middle" >GOTERM_BP_DIRECT</td><td align="center" valign="middle" >GO:0043406~positive regulation of MAP kinase activity</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >0.013368446</td><td align="center" valign="middle" >PIK3CG, PSEN1, RASGRP1, PIK3R5, PDGFD</td></tr><tr><td align="center" valign="middle" >GOTERM_CC_DIRECT</td><td align="center" valign="middle" >GO:0005794~Golgi apparatus</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >0.014210482</td><td align="center" valign="middle" >RNF144A, CLCN3, CPTP, NDST2, PPHLN1, OSBPL9, MINK1, CHEK2, PARP10, DSE, GLCE, HOOK3, HDAC5, LOC515551, PSEN1, SCYL1, ATP2C1, KIFAP3, RASGRP1, GOLGA1, LMTK2, NDRG2, SLC30A6, GOLGB1</td></tr><tr><td align="center" valign="middle" >KEGG_PATHWAY</td><td align="center" valign="middle" >bta04014:Ras signaling pathway</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >0.014339951</td><td align="center" valign="middle" >AKT1, PIK3CG, IGF1R, RASGRP3, MRAS, RASGRP1, NF1, MET, MAPK9, PLA2G4F, PIK3R5, PDGFD</td></tr><tr><td align="center" valign="middle" >GOTERM_BP_DIRECT</td><td align="center" valign="middle" >GO:0035556~intracellular signal transduction</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >0.015816518</td><td align="center" valign="middle" >SRPK2, ARHGEF2, ARHGEF6, ASB12, WNK1, ARHGEF12, RGS14, MAST3, TYK2, SH3BP5L, AKT1, PSEN1, PIKFYVE, NRG1, TEC</td></tr><tr><td align="center" valign="middle" >KEGG_PATHWAY</td><td align="center" valign="middle" >bta04510:Focal adhesion</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >0.016201172</td><td align="center" valign="middle" >AKT1, PIK3CG, IGF1R, MET, MAPK9, PIK3R5, PDGFD, THBS1, ITGB1, PARVB, ITGA2B</td></tr><tr><td align="center" valign="middle" >GOTERM_CC_DIRECT</td><td align="center" valign="middle" >GO:0015630~microtubule cytoskeleton</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >0.016532829</td><td align="center" valign="middle" >SHMT2, TAF1A, LYST, ATXN7, PMS2, TACC1, SPTAN1</td></tr><tr><td align="center" valign="middle" >GOTERM_BP_DIRECT</td><td align="center" valign="middle" >GO:0045071~negative regulation of viral genome replication</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >0.017309895</td><td align="center" valign="middle" >SRPK2, ILF3, PARP10, EIF2AK2</td></tr><tr><td align="center" valign="middle" >GOTERM_BP_DIRECT</td><td align="center" valign="middle" >GO:0001921~positive regulation of receptor recycling</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >0.017702846</td><td align="center" valign="middle" >PSEN1, SNCA, SCRIB</td></tr><tr><td align="center" valign="middle" >KEGG_PATHWAY</td><td align="center" valign="middle" >bta04810:Regulation of actin cytoskeleton</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >0.018272634</td><td align="center" valign="middle" >PIK3CG, ARHGEF1, ARHGEF6, MRAS, PIKFYVE, PIK3R5, PDGFD, ARHGEF12, ITGB1, FGD3, ITGA2B</td></tr><tr><td align="center" valign="middle" >KEGG_PATHWAY</td><td align="center" valign="middle" >bta04514:Cell adhesion molecules (CAMs)</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >0.020016292</td><td align="center" valign="middle" >BOLA, CD80, SELL, CD274, CD6, ITGB1, MGC126945, LOC616254</td></tr><tr><td align="center" valign="middle" >GOTERM_CC_DIRECT</td><td align="center" valign="middle" >GO:0048471~perinuclear region of cytoplasm</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >0.020196784</td><td align="center" valign="middle" >XRCC3, SEC24A, SNCA, OAS2, TPD52, ANGEL1, TARBP2, CYLD, RASGRP3, PIKFYVE, LMTK2, GOLGA1, USP20, PUM2, NDRG2, EIF2AK2, DCUN1D3, KLHL20</td></tr><tr><td align="center" valign="middle" >KEGG_PATHWAY</td><td align="center" valign="middle" >bta04151:PI3K-Akt signaling pathway</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >0.020322244</td><td align="center" valign="middle" >PIK3CG, RXRA, PPP2R5C, MET, FOXO3, ITGB1, RPTOR, AKT1, IGF1R, TSC1, JAK2, PIK3R5, PDGFD, THBS1, ITGA2B</td></tr><tr><td align="center" valign="middle" >GOTERM_BP_DIRECT</td><td align="center" valign="middle" >GO:0017148~negative regulation of translation</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >0.021050278</td><td align="center" valign="middle" >TSC1, TIA1, ILF3, EIF2AK2, SAMD4B</td></tr><tr><td align="center" valign="middle" >GOTERM_BP_DIRECT</td><td align="center" valign="middle" >GO:0031532~actin cytoskeleton reorganization</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >0.022851943</td><td align="center" valign="middle" >PHACTR1, ATP2C1, MINK1, RICTOR, PARVB</td></tr><tr><td align="center" valign="middle" >KEGG_PATHWAY</td><td align="center" valign="middle" >bta04068:FoxO signaling pathway</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >0.026066228</td><td align="center" valign="middle" >AKT1, PIK3CG, IGF1R, MAPK9, PIK3R5, FOXO3, ATM, STAT3</td></tr><tr><td align="center" valign="middle" >GOTERM_MF_DIRECT</td><td align="center" valign="middle" >GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >0.027075777</td><td align="center" valign="middle" >MEF2D, EGR2, FOXJ2, TFE3, MITF, NFAT5, TEF, ELK3, RBPJ, STAT3, NR1H3</td></tr><tr><td align="center" valign="middle" >GOTERM_BP_DIRECT</td><td align="center" valign="middle" >GO:0015012~heparan sulfate proteoglycan biosynthetic process</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >0.027472207</td><td align="center" valign="middle" >NDST2, DSE, GLCE</td></tr><tr><td align="center" valign="middle" >GOTERM_BP_DIRECT</td><td align="center" valign="middle" >GO:0007040~lysosome organization</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >0.0307095</td><td align="center" valign="middle" >TMEM106B, LYST, HOOK3, CLN6</td></tr><tr><td align="center" valign="middle" >GOTERM_CC_DIRECT</td><td align="center" valign="middle" >GO:0090575~RNA polymerase II transcription factor complex</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >0.030828201</td><td align="center" valign="middle" >RXRA, HIPK2, STAT3, NR1H3</td></tr><tr><td align="center" valign="middle" >KEGG_PATHWAY</td><td align="center" valign="middle" >bta04668:TNF signaling pathway</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >0.031389763</td><td align="center" valign="middle" >TRAF1, AKT1, PIK3CG, TRAF2, CASP7, MAPK9, PIK3R5</td></tr><tr><td align="center" valign="middle" >GOTERM_BP_DIRECT</td><td align="center" valign="middle" >GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >0.032191499</td><td align="center" valign="middle" >RNF144A, RMND5A, SIAH1, SMURF1, TRIP12, KLHL20, RNF111, LNX1</td></tr><tr><td align="center" valign="middle" >GOTERM_BP_DIRECT</td><td align="center" valign="middle" >GO:0050768~negative regulation of neurogenesis</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >0.0329965</td><td align="center" valign="middle" >ARHGEF2, PCM1, HOOK3</td></tr><tr><td align="center" valign="middle" >KEGG_PATHWAY</td><td align="center" valign="middle" >bta05166:HTLV-I infection</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >0.033073932</td><td align="center" valign="middle" >AKT1, PIK3CG, BOLA, ATF3, EGR2, MRAS, PIK3R5, CHEK2, MGC126945, ATM, BUB3</td></tr><tr><td align="center" valign="middle" >KEGG_PATHWAY</td><td align="center" valign="middle" >bta04550:Signaling pathways regulating pluripotency of stem cells</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >0.033273587</td><td align="center" valign="middle" >AKT1, PIK3CG, IGF1R, PCGF5, JARID2, JAK2, PIK3R5, STAT3</td></tr><tr><td align="center" valign="middle" >GOTERM_CC_DIRECT</td><td align="center" valign="middle" >GO:0005769~early endosome</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >0.03349405</td><td align="center" valign="middle" >CLN3, CLCN3, DYSF, DERL1, PHB, ZFYVE16, LMTK2, OCRL, ANKFY1</td></tr><tr><td align="center" valign="middle" >GOTERM_CC_DIRECT</td><td align="center" valign="middle" >GO:0005884~actin filament</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >0.035775146</td><td align="center" valign="middle" >TSC1, WIPF2, FKBP15, WHRN, TPM3</td></tr><tr><td align="center" valign="middle" >GOTERM_MF_DIRECT</td><td align="center" valign="middle" >GO:0000166~nucleotide binding</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >0.037351839</td><td align="center" valign="middle" >RALY, RBM12B, SETD1B, HNRNPA2B1, G3BP2, HNRNPDL, RCAN3, SLTM, SRSF4, LARP4, TIA1, CELF2, TNRC6B, HNRNPH1</td></tr><tr><td align="center" valign="middle" >GOTERM_BP_DIRECT</td><td align="center" valign="middle" >GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >0.037767923</td><td align="center" valign="middle" >RMND5A, PPP2R5C, RNF38, SIAH1, SMURF1, CLOCK, KLHL20, RNF111</td></tr><tr><td align="center" valign="middle" >KEGG_PATHWAY</td><td align="center" valign="middle" >bta05145:Toxoplasmosis</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >0.037943926</td><td align="center" valign="middle" >AKT1, TYK2, IL10RA, MAPK9, JAK2, ITGB1, STAT3</td></tr><tr><td align="center" valign="middle" >GOTERM_BP_DIRECT</td><td align="center" valign="middle" >GO:0035023~regulation of Rho protein signal transduction</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >0.03814075</td><td align="center" valign="middle" >ARHGEF2, ARHGEF1, ARHGEF6, ARHGEF12, FGD3, ARHGDIB</td></tr><tr><td align="center" valign="middle" >GOTERM_MF_DIRECT</td><td align="center" valign="middle" >GO:0046872~metal ion binding</td><td align="center" valign="middle" >41</td><td align="center" valign="middle" >0.038963827</td><td align="center" valign="middle" >PDP1, ZKSCAN7, ZNF469, HELZ, OAS2, DPH3, ZNF177, CNOT7, ITGB1, ZNF32, LOC100124497, ZFYVE16, POLM, ASPH, PHF20L1, ZNF575, FGD3, DUS3L, KLF7, ARHGEF2, ZBTB47, EGR2, ZC3H7A, KLF12, ADNP, ZNF142, MBNL1, ZNF333, RIMKLA, HDAC5, PPM1D, ZNF783, ZNF383, PLA2G4F, ZNF462, ZC3H11A, ANKFY1, KDM6B, ZNF484, ZNF572, ZNF436</td></tr><tr><td align="center" valign="middle" >GOTERM_CC_DIRECT</td><td align="center" valign="middle" >GO:0005640~nuclear outer membrane</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >0.039013613</td><td align="center" valign="middle" >CPTP, PSEN1, LTC4S</td></tr><tr><td align="center" valign="middle" >GOTERM_BP_DIRECT</td><td align="center" valign="middle" >GO:0008283~cell proliferation</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >0.039588703</td><td align="center" valign="middle" >USP28, USPL1, ECD, YME1L1, BRAT1, APPL2, TACC1, STAT3, SCRIB</td></tr><tr><td align="center" valign="middle" >KEGG_PATHWAY</td><td align="center" valign="middle" >bta04012:ErbB signaling pathway</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >0.040508847</td><td align="center" valign="middle" >AKT1, PIK3CG, CBLB, MAPK9, PIK3R5, NRG1</td></tr><tr><td align="center" valign="middle" >GOTERM_BP_DIRECT</td><td align="center" valign="middle" >GO:0045494~photoreceptor cell maintenance</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >0.040731561</td><td align="center" valign="middle" >IQCB1, PROM1, ERCC6, SPATA7</td></tr><tr><td align="center" valign="middle" >GOTERM_CC_DIRECT</td><td align="center" valign="middle" >GO:0000781~chromosome, telomeric region</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >0.040884325</td><td align="center" valign="middle" >SMC6, THOC7, CHEK2, ATM</td></tr><tr><td align="center" valign="middle" >KEGG_PATHWAY</td><td align="center" valign="middle" >bta04144:Endocytosis</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >0.041417674</td><td align="center" valign="middle" >IGF1R, BOLA, CBLB, FOLR2, RABEP1, ZFYVE16, WIPF2, SMURF1, MGC126945, ARAP1</td></tr><tr><td align="center" valign="middle" >GOTERM_MF_DIRECT</td><td align="center" valign="middle" >GO:0008270~zinc ion binding</td><td align="center" valign="middle" >35</td><td align="center" valign="middle" >0.042579019</td><td align="center" valign="middle" >TRAF1, TRAF2, SEC24A, SNCA, TTC3, LNX1, PCGF5, TRIM47, CYLD, TRIM6, RASGRP1, PIKFYVE, RNF38, CDADC1, MICAL1, ZDHHC20, KDM5C, NR1H3, RNF144A, DTX4, CGRRF1, ZMYM1, RXRA, ZMYM5, ZFR, CBLB, PHF3, KDM2B, PHF21A, USP20, SIAH1, KAT6B, ZFHX2, RERE, RNF111</td></tr><tr><td align="center" valign="middle" >GOTERM_MF_DIRECT</td><td align="center" valign="middle" >GO:0031490~chromatin DNA binding</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >0.045301309</td><td align="center" valign="middle" >RXRA, JMJD1C, FOXO3, STAT3, CLOCK</td></tr><tr><td align="center" valign="middle" >KEGG_PATHWAY</td><td align="center" valign="middle" >bta04071:Sphingolipid signaling pathway</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >0.048497673</td><td align="center" valign="middle" >AKT1, PIK3CG, TRAF2, PPP2R5C, MAPK9, PIK3R5, NSMAF</td></tr><tr><td align="center" valign="middle" >GOTERM_BP_DIRECT</td><td align="center" valign="middle" >GO:0016579~protein deubiquitination</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >0.051735245</td><td align="center" valign="middle" >USP28, USP40, USP11, USP20, USP42</td></tr><tr><td align="center" valign="middle" >GOTERM_CC_DIRECT</td><td align="center" valign="middle" >GO:0012506~vesicle membrane</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >0.051954441</td><td align="center" valign="middle" >TRAF2, CLCN3, PIKFYVE</td></tr><tr><td align="center" valign="middle" >GOTERM_CC_DIRECT</td><td align="center" valign="middle" >GO:0031519~PcG protein complex</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >0.051954441</td><td align="center" valign="middle" >PCGF5, KDM2B, UBAP2L</td></tr><tr><td align="center" valign="middle" >GOTERM_BP_DIRECT</td><td align="center" valign="middle" >GO:0032026~response to magnesium ion</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0.052393136</td><td align="center" valign="middle" >SNCA, THBS1</td></tr><tr><td align="center" valign="middle" >GOTERM_MF_DIRECT</td><td align="center" valign="middle" >GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >0.053461677</td><td align="center" valign="middle" >ZMYM1, FOXJ2, SNAPC4, PHB, ZMYM5, FOXJ3, FOXO3, ELK3, FOXS1</td></tr><tr><td align="center" valign="middle" >GOTERM_MF_DIRECT</td><td align="center" valign="middle" >GO:0004674~protein serine/threonine kinase activity</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >0.057021302</td><td align="center" valign="middle" >MAST3, AKT1, STK16, SRPK2, PRPF4B, HIPK2, WNK1, LMTK2, CHEK2, NEK7, CDKL4</td></tr><tr><td align="center" valign="middle" >KEGG_PATHWAY</td><td align="center" valign="middle" >bta04722:Neurotrophin signaling pathway</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >0.057046106</td><td align="center" valign="middle" >AKT1, PIK3CG, PSEN1, MAPK9, PIK3R5, FOXO3, ARHGDIB</td></tr><tr><td align="center" valign="middle" >KEGG_PATHWAY</td><td align="center" valign="middle" >bta04145:Phagosome</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >0.059172835</td><td align="center" valign="middle" >BOLA, PIKFYVE, ATP6V1H, TUBB1, THBS1, ITGB1, MGC126945</td></tr><tr><td align="center" valign="middle" >KEGG_PATHWAY</td><td align="center" valign="middle" >bta04664:Fc epsilon RI signaling pathway</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >0.059404884</td><td align="center" valign="middle" >AKT1, PIK3CG, MAPK9, PLA2G4F, PIK3R5</td></tr></tbody></table></table-wrap><p>in high RFI (less efficient) heifers. Ribosomal protein L17 protein is a cell growth inhibitor protein which may improve the muscle growth while down-regulated. Down-regulation of the cell signalling genes may re-model mitochondrial membrane in order to improve ROS through electron transport chain and other GTPases based energy balancing functions in cytoplasm. Down-regulation of SEPTIN 2 (GTPase) and Rabaptin (GTPase binding protein 1) genes may affect the cell signalling due to altered cell membrane and cell binding effector proteins. Down-regulation of regulation on GTPase signalling (G protein 14) may deplete energy in cytoplasm, thus affecting cell functions and growth in heifers. Down-regulation of LOC100295883 gene locus may implicate affected endometrial development and embryo implantation due to its role in lipid synthesis and Cytochrome P450 proteins (monooxygenase). Down-regulation of G protein-coupled membrane receptors (GPCR) genes may affect binding of receptors-transcription factors (tf) do alter the downstream regulation of nuclear mRNA transport, cell signalling thus, altering endocytosis hampering protein degradation and cell homeostasis in low efficient heifers. Pre-mRNA modification in terms of down-regulated miRNA biosynthesis might lower the rate of translation, and even transcription regressing the overall feed efficiency RNA binding protein (RBP) transcripts as down-regulated Zinc finger CCCH (ZC3H7A) gene in high RFI heifers. Down-regulated LOC508666 gene may hamper development and optimize the functioning of reproductive system in high RFI heifers. These findings corroborate the earlier reports [<xref ref-type="bibr" rid="scirp.124682-ref16">16</xref>] .</p><p>Low rate of oocyte cell division and mitogenesis may be the response to the same effect. Down-regulation of genes governing steroid synthesis, adaptive/innate immunity, endometrium development co-expressed with the low level of interferon induction against viral infection, immunologic response to gram-negative bacterial infections, MHC class I heavy chain and TNF signaling were profound in expression in 9 to 11 months age heifers. Down-regulation of receptors mediated desensitization of signaling molecules for T-cell activation and cytokine production maintain homeostasis of the immune response in growing heifers.</p></sec><sec id="s3_3_2"><title>3.3.2. Up-Regulated Genes</title><p>Total of 428 up-regulated genes were identified (Padj &lt; 8.81509190325442E−41 to 0.000226709239889707). Top up-regulated genes (Padj &lt; 0.05) comparing high RFI (low efficiency) heifers with low RFI heifers as control are listed in <xref ref-type="table" rid="table3">Table 3</xref> and discussed ahead.</p><p>Up regulation of RPL 26 protein, a 60 s ribosomal subunit gene indicates enhanced mRNA translation in muscle in efficiently growing animals as reported in Angus [<xref ref-type="bibr" rid="scirp.124682-ref17">17</xref>] .</p><p>Up-regulation of RBPJ gene in this study may influence its negative control on phagocyte oxidative burst due to repression in NADPH oxidase transcription in response to bacterial infection. Endogenous transmembrane of CLM-1 (LOC522174) gene remodelling to hold preferred energy deriving cycles in mitochondria. Up-regulation of Innate Immune System representing gene locus (LOC101903261) which regulates TNF-induced cellular inflammation response; T cell signaling and its activation (TEC); expression of cytokines IL-2, IL-3, IL-4, IL-5, granulocyte-macrophage colony-stimulating factor, Bubalus bubalis CMRF 35 like mol. 6, an immune-regulatory signaling entity, CD 46 mol. propagating T-cell proliferation/differentiation may compensate for body growth [<xref ref-type="bibr" rid="scirp.124682-ref18">18</xref>] . Ubiquitination Protein gene (USP25) and a stress responsive cell cycle regulator, peptidase like activity (USPLI) genes was up-regulated in efficient heifers.</p><p>Up-regulation of ATP2C1 gene (<xref ref-type="table" rid="table3">Table 3</xref>) known for ATP binding signal molecule as ligand for Golgi complex by promoting Ca transport and its secretion in cytoplasm, Up-regulation of cell growth enhancers for promoting transport of glucose, other sugars, bile salts, organic acids, metal ions and amine compounds, Solute carrier family 9 member A7 [SLC9 A7] protein gene involving endocytic pathways do establish homeostatic balance in cells. Up-regulation of Cardiac muscle contrac 2, ANKFY1 and Recombinant Signal binding protein for Ig Kappa J region [RBPJ], might improve energy metabolism in liver through enhancing Glutamate dehydrogenase 1 [GLUD1] activity and advocating Ammonia detoxification by deamination of Glutamate to 2-oxoglutarate (ATP generation), channeling dietary lipids and adipose triglycerides to the mitochondrial respiratory chain due to induced oxidation-reduction process and ETC, generating high levels of energy against the oxygen stress [<xref ref-type="bibr" rid="scirp.124682-ref18">18</xref>] was negatively correlated (P &lt; 0.05) with RFI efficiency and growth. Enhanced muscle mitochondrial respiration is known to associate with high RFI Angus steers [<xref ref-type="bibr" rid="scirp.124682-ref19">19</xref>] . High serum SGPT in this study [<xref ref-type="bibr" rid="scirp.124682-ref7">7</xref>] is linked with energy (NADPH) generation through Pyruvate diversion to Citric acid cycle [<xref ref-type="bibr" rid="scirp.124682-ref20">20</xref>] to compensate for growth, expectedly, in less efficient (high RFI) heifers. More than six GO terms related to glucose metabolism and signaling (glycolytic process, gluconeogenesis, pyruvate metabolic process were identified in response to insulin signaling (bta 04910) and Insulin resistance (bta 04931) identified in this study (<xref ref-type="table" rid="table4">Table 4</xref>) as ATP binding, AMPK signaling (bta 004152), GTPase activation (GO: 0090630, GO: 0005096, positive regulation of MAP Kinase (GO: 0043406). Also, GO terms related to oxidative metabolism (oxidation-reduction process, tricarboxylic acid cycle, proton transmembrane transport, oxaloacetate metabolic process, 2-oxoglutarate metabolic process, mitochondrial ATP synthesis coupled proton transport, and ATP biosynthetic process (Intracellular signal transduction GO: 0035556, microtubule cytoskeleton, GO; 0015630, Regulation of actin cytoskeleton (bta04810, GO: 0031532, GO: 0005884)and related genes which were identified in this study do corroborate with other reports [<xref ref-type="bibr" rid="scirp.124682-ref21">21</xref>] confirming the up-regulation of energy conserving genes and reduction in mitochondrial Oxidative phosphorylation do support feed efficient (low-RFI) animals.</p><p>Induced DNA-binding activity of transcription factors, e.g., MGA and NCOR1-HDAC3 genes (<xref ref-type="table" rid="table4">Table 4</xref>) may promote protein translation. Circadian expression of the core clock gene VIARTNL/BMAL1 nuclear receptor co-repressor 1 (NCOR1) gene known for altering lipid metabolism in liver may optimize body weight and growth related functions in response to oxidative stress. Fork head box transcription factor (FOXO), a Growth factor having potential role in expression of adherent genes and stress regulating transcription factors was up-regulated in this study thus, regulating cell cycle (bta 04514, GO: 0008283), energy intake and metabolic rate through Adipocytokine signaling pathway (bta04920) to combat with stress. FOXO, another transcription factor regulates Cortisol: glucocorticoid receptor complexing (GO: 2000323) in cytosol, translocating the same to nucleus and modulating transcription of a large battery of genes as fatty acid oxidation in muscles altering cell phenotype. mTOR protein kinase—a growth factor that coordinates cell growth (bta 04150) involving TNF signaling pathway (bta04668), immunity functions regulation by stimulating transcription factor Nuclear factor-kappa B (NF-kappa B) gene which regulates inflammation and cell survival. ErbB receptor tyrosine kinases pathway (bta 04012, <xref ref-type="table" rid="table4">Table 4</xref>) with downstream Mitogen-activated protein kinase (MAPK) pathway and phosphatidylinositol-3-kinase (PI-3K) pathway (bta: 04151, <xref ref-type="table" rid="table4">Table 4</xref>), for cell proliferation and differentiation through coupling extracellular growth factor ligands with intracellular signaling.</p><p>Recombination signal binding protein for immunoglobulin kappa J region (RBPJ) gene (<xref ref-type="table" rid="table4">Table 4</xref>) which negatively regulates the phagocyte oxidative burst in response to bacterial infection by repressing transcription of NADPH oxidase may add to feed efficiency in efficient heifers. Tubulin beta 1 (TUBB1) gene indicates need for higher expression of platelets production and platelet release (<xref ref-type="table" rid="table4">Table 4</xref>). LOC10084s 8700 gene locus up-regulation might be responsive towards stress in response to the toxic elements in liver of efficient, low RFI heifers symbolizing n adaptation of cell metabolism to combat conditions of oxidative stress. LOC523126 MRP4, a functional Prostaglandin carrier molecule known as regulator of estrous cycle up-regulated may be indicative of oocytes differentiation due to enhanced expression of XPO6 gene in efficient heifers which might induce early puberty. High metabolic activity is correlated with higher DMI for partitioning of energy for puberty attainment in less efficient heifers (22). CD46 gene is known for governing spermatozoa: Oocyte fusion which supports its role in fertilization and conception in buffalo heifers, while up-regulated. Present study identified Dynein gene (Axonemal dynein light chain domain containing 1 protein, AXDND1) up-regulation (log<sub>2</sub>FoldChange = 4.814, 4.814) (<xref ref-type="table" rid="table3">Table 3</xref> and <xref ref-type="table" rid="table4">Table 4</xref>) in heifers, playing a major role in energy production for sperm motility, [<xref ref-type="bibr" rid="scirp.124682-ref22">22</xref>] [<xref ref-type="bibr" rid="scirp.124682-ref23">23</xref>] thus having its suggestive role in reproduction.</p></sec></sec><sec id="s3_4"><title>3.4. Gene Enrichment Analysis</title><p>Significant GO terms enriched and the pathways identified (https://david.ncifcrf.gov/) in this study are listed in <xref ref-type="table" rid="table4">Table 4</xref>. Selected GO terms (Padj ≤ 0.05) were used as input to plot gene network (<xref ref-type="fig" rid="fig4">Figure 4</xref>) in respect of FCE trait. Clusters (Padj &lt; 0.05) that emerged in Cytoscape showed Intracellular</p><p>Transduction signals (GO: 0035556) as pronounced function in Biological Process (4.3%) followed by Cell migration and Cell proliferation (<xref ref-type="fig" rid="fig5">Figure 5</xref>).</p><p>Cytoplasm functions (GO: 0005737) were found more pronounced than Nucleoplasm (GO: 0005654) due to a higher number of genes (103) annotated with former than the latter (65 genes), respectively (<xref ref-type="table" rid="table4">Table 4</xref>), sharring 9.8% of Cellular component (<xref ref-type="fig" rid="fig5">Figure 5</xref>) term, however, transcripts of genes governing transcriptional regulation in nucleus were emerged and annotated by Nucleoplasm (GO: 0005654) significantly (Padj &lt; 0.05) (<xref ref-type="table" rid="table4">Table 4</xref>). GO: terms annotated by high rate of energy dependent translational changes as ATP binding (GO: 0005524), Metal Ion binding (GO: 0046872), Zinc Ion binding (GO; 0008270, bta04151) (<xref ref-type="table" rid="table4">Table 4</xref>), corroborate with the energy related genes reported earlier as Rap 1 gene, [<xref ref-type="bibr" rid="scirp.124682-ref24">24</xref>] which harvests MAP kinase activity [<xref ref-type="bibr" rid="scirp.124682-ref25">25</xref>] to regulate body weight and feed intake in cattle [<xref ref-type="bibr" rid="scirp.124682-ref26">26</xref>] [<xref ref-type="bibr" rid="scirp.124682-ref27">27</xref>] . The Rap1 (bta 04015) and Ras signalling (bta 04014) pathways emerged as enriched (P &lt; 0.05, FDR in range of 0.00174998654944857 to 58.5661012869287) pathways (<xref ref-type="table" rid="table4">Table 4</xref>) as regulator of fatty acid content in response to retinoic acid and glycerol transport [<xref ref-type="bibr" rid="scirp.124682-ref28">28</xref>] in higher feed efficiency heifers.</p><p>Up-regulation of regulatory function genes for ATP binding (bta 04152: AMPK signalling pathway (<xref ref-type="table" rid="table4">Table 4</xref>) in B cell activation in present study along with MHC class I protein complex (presenting intra-cellular degraded proteins to cytotoxic T cells); GTPase activity, cell proliferation and differentiation, proteins translocation, signal transduction through transmembrane receptors, followed by subsequent protein synthesis at ribosome, as reported earlier [<xref ref-type="bibr" rid="scirp.124682-ref29">29</xref>] and Platelet activation (bta04611, <xref ref-type="table" rid="table4">Table 4</xref>) [<xref ref-type="bibr" rid="scirp.124682-ref30">30</xref>] are expected physiological processes in efficient feed utilizing (low-RFI) heifers for achieving higher weight gain by reduced feed intake thus, lowering the input price as compared to rearing the less efficient counterparts.</p></sec><sec id="s3_5"><title>3.5. System Biology Analysis</title><p>Biological analysis of transcripts (Padj &lt; 0.05) obtained from system biology analysis was summarized in GO summary (GO: terms and pathways) (<xref ref-type="table" rid="table4">Table 4</xref>). The DEGs identified were annotated by 93 GO terms/pathways enriched, allocated to the category of post transcriptional regulation and chromatin organization in Nucleus, Cell energy balancing, Immunity, hormonal regulation functions and Cell signaling including the biological pathways as Rap1, Notch, Prolactin, Osteoclast differentiation, m TOR, Ras, PI3K-AKT, FoxO, TNF, ErbB and Sphingolipid. High RFI heifers were associated with high IGF1 (p &lt; 0.05) and other blood parameters such as Cholesterol and Triglycerides (p &lt; 0.001) as reported in buffalo heifers [<xref ref-type="bibr" rid="scirp.124682-ref7">7</xref>] and cattle [<xref ref-type="bibr" rid="scirp.124682-ref31">31</xref>] .</p><p>Feed utilization is an energy dependent function requiring availability of higher reducing power to maintain optimum productivity [<xref ref-type="bibr" rid="scirp.124682-ref7">7</xref>] . Metabolic profile differs in high and low RFI heifers. High level of IGF1 has a positive correlation with LDL, HDL fat and SGPT enzyme in this study [<xref ref-type="bibr" rid="scirp.124682-ref7">7</xref>] and might favor the deposition of fat by channeling free triglycerides (P &lt; 0.05) toward muscle tissue to gain weight in less efficient animals. Lower blood level of non-esterified fatty acids and higher muscle growth has been reported in low RFI cattle [<xref ref-type="bibr" rid="scirp.124682-ref32">32</xref>] and pig [<xref ref-type="bibr" rid="scirp.124682-ref20">20</xref>] . Thus, IGF-1 is recognized as a potential biological marker for FE/RFI, in dairy heifers [<xref ref-type="bibr" rid="scirp.124682-ref7">7</xref>] and beef cattle [<xref ref-type="bibr" rid="scirp.124682-ref33">33</xref>] determining a negative correlation between RFI efficiency and circulatory level of IGF-1 [<xref ref-type="bibr" rid="scirp.124682-ref34">34</xref>] in heifers. However, the systemic IGF-I concentration is known to be influenced by environment also [<xref ref-type="bibr" rid="scirp.124682-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.124682-ref14">14</xref>] . In the contrary, a positive genetic relationship between plasma IGF-I level and RFI in sheep [<xref ref-type="bibr" rid="scirp.124682-ref35">35</xref>] has been reported. RFI DEGs may not be comparable with respect to age, breed and physiological status. However, feeding management and climate change may be the additive factors influencing the DEG patterns.</p><p>Differentially expressed genes in respect of RFI efficiency trait are listed the first time in Murrah dairy growing heifers. DG patterns were obtained comparing blood transcriptome [<xref ref-type="bibr" rid="scirp.124682-ref21">21</xref>] data obtained from low and high RFI heifers tried on controlled feeding trials. Feed efficiency is a complex functional expression resulting from the synergism between energy built-up (ATP synthesis) and growth reflected through basal metabolic rate, homeostatic control of body, immune response through lipid metabolism and hepatic inflammation respectively [<xref ref-type="bibr" rid="scirp.124682-ref18">18</xref>] .</p><p>A large variation (p &lt; 0.05) in DMI and average daily weight gain (ADG) over young heifers maintained under common management was attributed to the difference in their respective feed utilization efficiency. Feed efficiency was estimated as the residual feed intake (RFI Kg/h/d) in this study. DMI (kg/h/d) was 13.14% lower in the low RFI heifers as compared to high RFI heifers. It hypothesized feed efficiency as a selection trait due to underlying variation expected in genetic make-up of these animals. Feed input cost can be significantly reduced by selective breeding of feed efficient heifers. Variation in RFI is pertinent to metabolism [<xref ref-type="bibr" rid="scirp.124682-ref36">36</xref>] of individual animal which is translated into low consistency in phenotypic growth and RFI.</p><p>Hierarchical clustering of differentially expressed transcripts obtained from high and low RFI heifers showed no common transcripts in categories of up and down regulated genes. It supports the selection proposal of the animals in high and low RFI subgroups, especially having common transcripts between the two groups being non-significant in enrichment analysis. The identified set of deregulated genes that were obtained from the analysis are considered as a fingerprint of differences in metabolic homeostasis. This leads to variation in growth rates that are governed by the underlying genetic potential of the heifers. Hence, these transcripts can be used to identify extreme FE phenotypes in buffaloes.</p><p>Immune response emerges as a potential body function underlying the biological variation in RFI in this study. Immunity is an energetically costly physiological process [<xref ref-type="bibr" rid="scirp.124682-ref37">37</xref>] as higher incidences of chronic inflammation are expected in high-RFI cattle, consequently making less energy available for growth. Down regulation of genes governing the immune functions indicates low immunity in the high-RFI heifers as reported earlier [<xref ref-type="bibr" rid="scirp.124682-ref19">19</xref>] , thus affecting the efficiency of feed utilization. It is consistent with the regular/increased level of immunity governing gene expression in energy efficient manner as reported in low-RFI cattle [<xref ref-type="bibr" rid="scirp.124682-ref38">38</xref>] [<xref ref-type="bibr" rid="scirp.124682-ref39">39</xref>] .</p><p>Efficient (low RFI) heifers showing down-regulated ROS function genes suggest the lower energy expenditure for metabolic function to achieve growth in feed efficient heifers. Genes related to lipid transport and energy production were up-regulated probably, in response to high ROS in the high-DMI group of less efficient animals. High-ADG is consistently increased in response to carbohydrate and lipid transport in favor of cell differentiation.</p></sec></sec><sec id="s4"><title>4. Conclusion</title><p>The present study highlights the genes underpinning RFI efficiency in buffalo growing heifers, which certainly is a less studied trait in Indian buffaloes. The DEGs identified from the study can be used as a resource of biomarkers for developing molecular signature markers for the selection of RFI traits. Underlying biological processes of FCE are complex and are influenced by diverse climates, feed properties consequent to different gut microbiota, and individual genetic predisposition. FCE determinant, i.e., RFI being a promising tool for selection has moderate genomic heritability in a range between 0.18 to 0.57 in cattle, but is independent of age, growth and body weight (BW) traits where, the feed intake, body weight, and weight gain do carry moderate heritability. Thus, the validation of DEs can be done by including animals of different developmental and physiological stages, with a view to examining their ability to maintain energy balance and sustain immunity. For more effective breeding plans, RFI DEGs and pathways identified in heifers will improve the knowledge of QTL links in favour of related functional traits such as fertility and growth predictions in heifers. Information on genomic regions harbouring the variant genes [<xref ref-type="bibr" rid="scirp.124682-ref40">40</xref>] can be utilized to analyze additional markers like CNV (Copy Number Variation) for developing genomic selection programmes.</p></sec><sec id="s5"><title>Ethics Statements</title><p>The animal study was reviewed and approved by the Institute Animal Ethics Committee (IAEC) of CIRB Hisar. India (Reg. No. 406/GO/RBI/L/01/CPCSEA).</p></sec><sec id="s6"><title>Supplementary Material and Data Access/Availability</title><p>RNA Sequence data has been submitted to the GenBank NCBI databases under SRA ID SUB5692555. SUB5733459 and the Bio Project ID: PRNA546485 Title: Locus tag prefixes: FHP27 (samn11959988) None (SAMN120577830).</p></sec><sec id="s7"><title>Funding</title><p>The research work [ICAR-CIRB-IASRI Collaboration] was supported by the Network Project on Agricultural Bioinformatics and Computation Biology under the Centre for Agricultural Bioinformatics Scheme, ICAR-IASRI, Indian Council of Agricultural Research (ICAR), New Delhi, INDIA as/Project Code AGENIASRICIP201500900046.</p></sec><sec id="s8"><title>Conflicts of Interest</title><p>The period of financial grant remained as April 2016-December 2018. The authors declare no conflict of interest with respect to this research.</p></sec><sec id="s9"><title>Cite this paper</title><p>Sikka, P., Paul, S.S., Jerome, A., Mishra, D., Chaturvedi, K.K., Singh, I. and Rai, A. (2023) Functional Genes in Relation to Residual Feed Intake in Murrah Buffalo Heifers. Advances in Bioscience and Biotechnology, 14, 210-236. https://doi.org/10.4236/abb.2023.144014</p></sec></body><back><ref-list><title>References</title><ref id="scirp.124682-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Connor, E.J., Hutchison, H., Norman, K., Olson, C., Van Tassell, J. and Baldwin, R. (2013) Use of Residual Feed Intake in Holsteins during Early Lactation Shows Potential to Improve Feed Efficiency through Genetic Selection. Journal of Animal Science, 91, 3978-3988. https://doi.org/10.2527/jas.2012-5977</mixed-citation></ref><ref id="scirp.124682-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Koch, R.M., Swiger, L.A., Chambers, D. and Gregory, K. (1963) Efficiency of Feed Use in Beef Cattle. Journal of Animal Science, 22, 486-494.  
https://doi.org/10.2527/jas1963.222486x</mixed-citation></ref><ref id="scirp.124682-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Bisitha, K., Chandra, B.S., Singh, K.S., et al. (2014) Residual Feed Intake as a Feed Efficiency Selection Tool and Its Relationship with Feed Intake, Performance and Nutrient Utilization in Murrah Buffalo Calves. Tropical Animal Health and Production, 46, 615-621. https://doi.org/10.1007/s11250-014-0536-2</mixed-citation></ref><ref id="scirp.124682-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Ser&amp;#227;o, N.V.L., González-Pe&amp;#241;a, D., Beever, J.E., Faulkner, D.B., Southey, B.R. and Rodriguez-Zas, S.L. (2013) Single Nucleotide Polymorphisms and Haplotypes Associated with Feed Efficiency in Beef Cattle. BMC Genetics, 14, Article No. 94.  
http://www.biomedcentral.com/1471-2156/14/94  
https://doi.org/10.1186/1471-2156-14-94</mixed-citation></ref><ref id="scirp.124682-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Kahi, A.K. and Hirooka, H. (2007) Effect of Direct and Indirect Selection Criteria for Efficiency of Gain on Profitability of Japanese Black Cattle Selection Strategies. Journal of Animal Science, 85, 2401-2412. https://doi.org/10.2527/jas.2006-713</mixed-citation></ref><ref id="scirp.124682-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Brito, L.F., Oliveira, H.R., Houlahan, K., Fonseca, P.S., Lam, S., et al. (2020) Genetic Mechanisms Underlying Feed Utilization and Implementation of Genomic Selection for Improved Feed Efficiency in Dairy Cattle. Canadian Journal of Animal Science, 100, 587-604. https://doi.org/10.1139/cjas-2019-0193</mixed-citation></ref><ref id="scirp.124682-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Poonam, S., Nath, A., Sundar, S., Jerome, P., et al. (2020) Inferring Relationship of Blood Metabolic Changes and Average Daily Gain with Feed Conversion Efficiency in Murrah Heifers: Machine Learning Approach. Frontiers in Veterinary Science, Section Animal Nutrition and Metabolism, 7, 518.  
https://doi.org/10.3389/fvets.2020.00518</mixed-citation></ref><ref id="scirp.124682-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Salleh, M.S., Mazzoni, G., Nielsen, M.O., L&amp;#248;vendah, P. and Kadarmideen, H.N. (2018) Identification of Expression QTLs Targeting Candidate Genes for Residual Feed Intake in Dairy Cattle Using Systems Genomics. Journal of Genetics and Genome Research, 5, 35. https://doi.org/10.23937/2378-3648/1410035</mixed-citation></ref><ref id="scirp.124682-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Patel, R.K. and Jain, M. (2012) NGS QC Toolkit: A Toolkit for Quality Control of Next Generation Sequencing Data. PLOS ONE, 7, e30619.  
https://doi.org/10.1371/journal.pone.0030619</mixed-citation></ref><ref id="scirp.124682-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Huang, D.W., Sherman, B.T., Tan, Q., Collins, J.R., et al. (2007) The DAVID Gene Functional Classification Tool: A Novel Biological Module-Centric Algorithm to Functionally Analyze Large Gene Lists. Genome Biology, 8, R183.  
https://doi.org/10.1186/gb-2007-8-9-r183</mixed-citation></ref><ref id="scirp.124682-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Bray, N.L., Pimentel, H., Melsted, P. and Pachter, L. (2016) Near-Optimal Probabilistic RNA-seq Quantification. Nature Biotechnology, 34, 525-527.  
https://doi.org/10.1038/nbt.3519</mixed-citation></ref><ref id="scirp.124682-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Love, M.I., Huber, W. and Anders, S. (2014) Moderated Estimation of Fold Change and Dispersion for RNA-seq Data with DESeq2. Genome Biology, 15, 550.  
https://doi.org/10.1186/s13059-014-0550-8</mixed-citation></ref><ref id="scirp.124682-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Shannon, P., Markiel, A., Ozier, O., Baliga, N.S., Wang, J.T., Ramage, D., Amin, N., Schwikowski, B. and Ideker, T. (2003) Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks. Genome Research, 13, 2498-2504. https://doi.org/10.1101/gr.1239303</mixed-citation></ref><ref id="scirp.124682-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Richardson, E.C., Herd, R.M., Archer, J.A. and Arthur, P.F. (2004) Metabolic Differences in Angus Steers Divergently Selected for Residual Feed Intake. Australian Journal of Experimental Agriculture, 44, 441-452. https://doi.org/10.1071/EA02219</mixed-citation></ref><ref id="scirp.124682-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Herd, R.M. and Arthur, P.F. (2009) Physiological Basis for Residual Feed Intake. Journal of Animal Science, 87, E64-E71. https://doi.org/10.2527/jas.2008-1345</mixed-citation></ref><ref id="scirp.124682-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">McKenna, C., Keogh, K., Porter, R.K., Waters, S.M., Cormican, P. and Kenny, D.A. (2021) An Examination of Skeletal Muscle and Hepatic Tissue Transcriptomes from Beef Cattle Divergent for Residual Feed Intake. Scientific Reports, 11, Article No. 8942. https://doi.org/10.1038/s41598-021-87842-3</mixed-citation></ref><ref id="scirp.124682-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Tizioto, P.C., Coutinho, L.L., Priscila, S.N., Aline, O., Cesar, S.M., Diniz, W.J.S., et al. (2016) Gene Expression Differences in Longissimus Muscle of Nelore Steers Genetically Divergent for Residual Feed Intake. Scientific Reports, 6, Article No. 39493. https://doi.org/10.1038/srep39493</mixed-citation></ref><ref id="scirp.124682-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Salleh, M.S., Mazzoni, G., H&amp;#246;glund, J.K., Olijhoek, D.W., Lund, P., L&amp;#248;vendah, H.N. and Kadarmideen, P. (2017) RNA-Seq Transcriptomics and Pathway Analyses Reveal Potential Regulatory Genes and Molecular Mechanisms in High- and Low-Residual Feed Intake in Nordic Dairy Cattle. BMC Genomics, 18, Article No. 258. https://doi.org/10.1186/s12864-017-3622-9</mixed-citation></ref><ref id="scirp.124682-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Kolath, W.H., Kerley, M.S., Golden, J.W. and Keisler, D.H. (2006) The Relationship between Mitochondrial Function and Residual Feed Intake in Angus Steers. Journal of Animal Science, 84, 861-865. https://doi.org/10.2527/2006.844861x</mixed-citation></ref><ref id="scirp.124682-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Hoque, M.A. and Suzuki, K. (2009) Genetics of Residual Feed Intake in Cattle and Pigs: A Review Asian-Aust. Journal of Animal Science, 22, 747-755.  
https://doi.org/10.5713/ajas.2009.80467</mixed-citation></ref><ref id="scirp.124682-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Bazile, J., Jaffrezic, F., Dehais, P., et al. (2020) Molecular Signatures of Muscle Growth and Composition Deciphered by the Meta-Analysis of Age-Related Public Transcriptomics Data. Physiological Genomics, 52, 322-332.  
https://doi.org/10.1152/physiolgenomics.00020.2020</mixed-citation></ref><ref id="scirp.124682-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">McConnell, J.D., Stone, D.K., Johnson, L. and Wilson, J.D. (1987) Partial Purification and Characterization of Dynein Adenosine Triphosphatase from Bovine Sperm. Biology of Reproduction, 37, 385-393.  
https://doi.org/10.1095/biolreprod37.2.385</mixed-citation></ref><ref id="scirp.124682-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Lorch, D.P., Lindemann, C.B. and Hunt, A.J. (2008) The Motor Activity of Mammalian Axonemal Dynein Studied in Situ on Doublet Microtubules. Cell Motility and the Cytoskeleton, 65, 487-494. https://doi.org/10.1002/cm.20277</mixed-citation></ref><ref id="scirp.124682-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Oliveira, P.S.N., Coutinho, L.L., Tizioto, P.C., Cesar, A.S.M., de Oliveira, G.B., et al. (2018) An Integrative Transcriptome Analysis Indicates Regulatory mRNA-miRNA Networks for Residual Feed Intake in Nelore Cattle. Scientific Reports, 8, Article No. 17072. https://doi.org/10.1038/s41598-018-35315-5</mixed-citation></ref><ref id="scirp.124682-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Kooistra, M.R.H., Dube, N. and Bos, J.L. (2006) Rap1: A Key Regulator in Cell-Cell Junction Formation. Journal of Cell Science, 120, 17-22.  
https://doi.org/10.1242/jcs.03306</mixed-citation></ref><ref id="scirp.124682-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Nkrumah, J.D., Li, C., Basarab, J.B., Guercio, S., Meng, Y., Murdoch, B., Hansen, C. and Moore, S.S. (2004) Association of a Single Nucleotide Polymorphism in the Bovine Leptin Gene with Feed Intake, Feed Efficiency, Growth, Feeding Behavior, Carcass Quality and Body Composition. Canadian Journal of Animal Science, 84, 211-219. https://doi.org/10.4141/A03-033</mixed-citation></ref><ref id="scirp.124682-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Hoehn, K.L., Hudachek, S.F., Summers, S.A. and Florant, G.L. (2004) Seasonal, Tissue-Specific Regulation of Akt/Protein Kinase B and Glycogen Synthase in Hibernators. The American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 286, R498-R504. https://doi.org/10.1152/ajpregu.00509.2003</mixed-citation></ref><ref id="scirp.124682-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Feitosa, F.L.B., Pereira, A.S.C., Mueller, L.F., de Souza Fonseca, P.A., Braz, C.U., Amorin, S., Espigolan, R., et al. (2021) Genome-Wide Association Study for Beef Fatty Acid Profile Using Haplotypes in Nellore Cattle. Livestock Science, 245, Article ID: 104396. https://doi.org/10.1016/j.livsci.2021.104396</mixed-citation></ref><ref id="scirp.124682-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Khansefid, M., Millen, C.A., Chen, Y., Pryce, J.E., Chamberlain, A.J., Vander Jagt, C.J., Gondro, C. and Goddard, M.E. (2017) Gene Expression Analysis of Blood, Liver, and Muscle in Cattle Divergently Selected for High and Low Residual Feed Intake. Journal of Animal Science, 95, 4764-4775.  
https://doi.org/10.2527/jas2016.1320</mixed-citation></ref><ref id="scirp.124682-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Oshurkova, J.L. and Glagoleva, T.I. (2017) Physiological Activity of Platelet Aggregation in Calves of Vegetable Feeding. Biomedical and Pharmacology Journal, 10, 1395-1400. https://doi.org/10.13005/bpj/1244</mixed-citation></ref><ref id="scirp.124682-ref31"><label>31</label><mixed-citation publication-type="book" xlink:type="simple">Basarab, J.A., et al. (2010) Interactions with Other Traits: Reproduction and Fertility. In: Hill, R.A., Ed., Feed Efficiency in the Beef Industry, John Wiley &amp; Sons, Hoboken, 123-144.</mixed-citation></ref><ref id="scirp.124682-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Xi, Y.M., Wu, F., Zhao, D.Q. and Yang, Z. (2016) Biological Mechanisms Related to Differences in Residual Feed Intake in Dairy Cows. Animal, 10, 1311-1318.  
https://doi.org/10.1017/S1751731116000343</mixed-citation></ref><ref id="scirp.124682-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Wood, B.J., Archer, J.A. and van der Werf, J.H.H. (2004) Response to Selection in Beef Cattle Using IGF-1 as a Selection Criterion for Residual Feed Intake under Different Australian Breeding Objectives. Livestock Production Science, 91, 69-81. 
https://doi.org/10.1016/j.livprodsci.2004.06.009</mixed-citation></ref><ref id="scirp.124682-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Kelly, A.K., McGee, M., Crews, D.H., Fahey, A.G., Wylie, A.R. and Kenny, D.A. (2010) Effect of Divergence in Residual Feed Intake on Feeding Behavior, Blood Metabolic Variables, and Body Composition Traits in Growing Beef Heifers. Journal of Animal Science, 88, 109-123. https://doi.org/10.2527/jas.2009-2196</mixed-citation></ref><ref id="scirp.124682-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Welch, C.M., Thornton, K.J., Murdoch, G.K., Chapalamadugu, K.C., Schneider, C.S., Ahola, J.K., Hall, J.B., Price, W.J. and Hill, R.A. (2013) An Examination of the Association of Serum IGF-I Concentration, Potential Candidate Genes, and Fiber Type Composition with Variation in Residual Feed Intake in Progeny of Red Angus Sires Divergent for Maintenance Energy EPD. Journal of Animal Science, 91, 5626-5636. https://doi.org/10.2527/jas.2013-6609</mixed-citation></ref><ref id="scirp.124682-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Sharma, V.K., Kundu, S.S., Datt, C., Prusty, S., Kumar, M. and Sontakke, U.B. (2017) Buffalo Heifers Selected for Lower Residual Feed Intake Have Lower Feed Intake, Better Dietary Nitrogen Utilisation and Reduced Enteric Methane Production. Journal of Animal Physiology and Animal Nutrition (Berlin), 102, e607-e614.  
https://doi.org/10.1111/jpn.12802</mixed-citation></ref><ref id="scirp.124682-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Alexandre, P.A., Kogelman, J., Santana, M.H., Passarelli, P.D., Fantinato-neto, H., Silva, P.P.L., Leme, P.R., Strefezzi, R.F., Coutinho, L., Ferraz, J.B., Eler, J.P., Kadarmideen, H.N. and Fukumasu, H. (2015) Liver Transcriptomic Networks Reveal Main Biological Processes Associated with Feed Efficiency in Beef Cattle. BMC Genomics, 16, Article No. 1073. https://doi.org/10.1186/s12864-015-2292-8</mixed-citation></ref><ref id="scirp.124682-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">Paradis, F., Yue, S., Grant, J., Stothard, P., Basarab, J. and Fitzsimmons, C. (2015) Transcriptomic Analysis by RNA Sequencing Reveals That Hepatic Interferon-Induced Genes May Be Associated with Feed Efficiency in Beef Heifers. Journal of Animal Science, 93, 3331-3341. https://doi.org/10.2527/jas.2015-8975</mixed-citation></ref><ref id="scirp.124682-ref39"><label>39</label><mixed-citation publication-type="other" xlink:type="simple">Weber, K.L., Welly, B.T., Van Eenennaam, A.L., Young, A.E., Porto-neto, L.R., Reverter, A. and Rincon, G. (2016) Identification of Gene Networks for Residual Feed Intake in Angus Cattle Using Genomic Prediction and RNA-seq. PLOS ONE, 11, e0152274. https://doi.org/10.1371/journal.pone.0152274</mixed-citation></ref><ref id="scirp.124682-ref40"><label>40</label><mixed-citation publication-type="other" xlink:type="simple">Mishra, D.C., Sikka, P., Yadav, S., Bhati, J., Paul, S.S., Jerome, A., et al. (2020) Identification and Characterization of Trait-Specific SNPs Using ddRAD Sequencing in Water Buffalo. Genomics, 112, 3571-3578.  
https://doi.org/10.1016/j.ygeno.2020.04.012</mixed-citation></ref></ref-list></back></article>